Targeting malaria elimination : an assessment of malaria control interventions for children in Zanzibar by Beer, Netta
 From the Department of Public Health Sciences 
Division of Global Health (IHCAR) 
Karolinska Institutet, Stockholm, Sweden 
 
TARGETING MALARIA 
ELIMINATION:  
AN ASSESSMENT OF 
MALARIA CONTROL 
INTERVENTIONS FOR 
CHILDREN IN ZANZIBAR 
 
 
Netta Beer 
 
 
Stockholm 2012 
 
Cover photo: Khaalidat Mwinyi Msellem demonstrating how to use a long-lasting 
insecticidal net (not a study participant) 
All previously published papers were reproduced with permission from the publisher. 
Published by Karolinska Institutet.  
Printed by Larserics Digital Print AB 
 
© Netta Beer, 2012 
ISBN 978-91-7457-850-8
  
 
 
"Oh Mama Africa 
so much love, so much spite;  
so much happiness, so much sadness; 
so rich, so poor;  
so honest, so corrupt;  
so much life, and yet so much death. 
You are indeed extreme, but you hold our hearts…" 
 
 
Judi Palmer (after the Zanzibar ferry accident, September 2011) 
  
 
 ABSTRACT 
Background: After decades of neglect, a renewed global focus on malaria was initiated 
in the 90s, followed by global financial support in the early 2000s. Zanzibar has been in 
the forefront of these renewed efforts: Case management and vector-control 
interventions have been implemented and scaled-up rapidly, resulting in markedly 
reduced malaria transmission and the targeting of malaria elimination. 
Aim: The overall aim of this thesis was to assess caretakers' uptake of malaria control 
interventions for under-five children in Zanzibar, an area where malaria transmission 
has rapidly decreased.  
Methods: In Study I, a follow-up survey of 210 caretakers was performed to assess 
caretaker adherence to Artemisinin-based Combination Therapies (ACTs), where 
caretakers were interviewed in their homes four days after receiving the three-day 
treatment for their children. In Studies II & III, an assessment of the effective coverage 
of vector control interventions was carried out in two community-based surveys in 
2006 and 2009, with 509 and 560 caretakers, respectively. Both surveys were done in 
North A and Micheweni districts. In the 2006 survey, the system effectiveness of a 
targeted free mass distribution of long-lasting insecticidal nets (LLINs) was also 
assessed, and in the 2009 survey, caretaker perceptions of the malaria situation in 
Zanzibar and of vector control interventions, were evaluated. Perceptions of malaria 
and vector control interventions were further explored by conducting in-depth 
interviews with 19 caretakers (Study IV).  
Results: Moderate adherence of 77% to Artesunate-Amodiaquine (AsAq) was 
documented, and was mostly due to misunderstanding or forgetting the correct dose 
regimen. Factors associated with adherence were caretaker's education exceeding 7 
years and receiving the exact number of pills to complete the treatment regimen, while 
administering the first dose at the health facility resulted in complete adherence (I). 
System effectiveness of the targeted mass distribution had increased in the distribution 
scale-up in North A district as compared to the pilot distribution in Micheweni. This 
resulted in high (87%) and equitable effective coverage of LLINs in under-five children 
in the North A district. Effective coverage was associated with receiving an LLIN and 
thinking that LLINs were better than conventional nets (II). Effective coverage of 
LLINs in under-fives in the 2009 survey was also equitable and relatively high (70%) 
following an un-targeted mass distribution, while effective coverage of IRS was as high 
as 95%, resulting in almost perfect effective coverage (98%) of at least one vector 
control intervention (III). Seasonality was found to interrupt continuous adherence to 
bed-nets (III & IV).  Low risk perceptions of malaria (III & IV) were not significantly 
associated with effective coverage (III), although the higher perceived risk for children 
is in line with the finding that children were prioritized for use of bed-nets (III & IV). 
Vector control interventions were generally well accepted (II-IV), and caretakers 
appreciated the importance of their continued use as malaria further declines (III).     
Conclusions: Findings of this thesis indicate that caretaker uptake of malaria control 
interventions for children remains high in Zanzibar in the face of declining malaria 
burden. ACTs, freely provided at public health facilities, were relatively well adhered 
to, and the high effective coverage of IRS, together with satisfactory effective coverage 
of LLINs, provided an almost perfect effective coverage of vector control interventions. 
This high effective coverage elevates the prospects of achieving malaria elimination in 
Zanzibar. 
Key words: Zanzibar; malaria; elimination; bed-nets; long-lasting insecticidal nets; 
LLIN; indoor-residual spraying; IRS; effective coverage; adherence; access; artesunate; 
amodiaquine; artemisinin-based combination therapies; ACT 
  
 
LIST OF PUBLICATIONS 
 
I.  Beer N, Ali AS, Rotllant G, Abass AK, Omari RS, Al-Mafazy AW, Björkman 
A, Källander K (2009) Adherence to artesunate-amodiaquine combination 
therapy for uncomplicated malaria in children in Zanzibar, Tanzania. Tropical 
Medicine & International Health 14:766-74. 
 
II. Beer N, Ali AS, de Savigny D, Al-Mafazy AW, Ramsan M, Abass AK, Omari 
RS,  Björkman A, Källander K (2010) System effectiveness of a targeted free 
mass distribution of long lasting insecticidal nets in Zanzibar, Tanzania. Malaria 
Journal 9:173 (9 pp). 
 
III. Beer N, Ali AS, Shakely D, Elfving K, Al-Mafazi AW, Msellem M, Björkman 
A, Källander K. High effective coverage of vector control interventions in 
children after achieving low transmission in Zanzibar, Tanzania. Submitted 
(2012). 
 
IV. Beer N, Ali AS, Eskilsson H, Jansson A, Abdul-Kadir FM, Rotllant-Estelrich 
G, Abass AK, Wabwire-Mangen F, Björkman A, Källander K. A qualitative 
study on caretakers' perceived need of bed-nets after reduced malaria 
transmission in Zanzibar, Tanzania. Accepted for publication in BMC Public 
Health (2012). 
 
 CONTENTS 
List of abbreviations ............................................................................................ 9 
Definitions .......................................................................................................... 10 
Preface ................................................................................................................ 11 
Background ........................................................................................................ 12 
Malaria ........................................................................................................ 12 
Epidemiology .................................................................................... 12 
Malaria control .................................................................................. 13 
History of malaria control ................................................................ 16 
From efficacy to effectiveness ................................................................... 19 
Efficacy ............................................................................................. 19 
Access  ............................................................................................... 20 
Adherence ......................................................................................... 20 
System effectiveness and effective coverage ................................... 22 
Zanzibar ...................................................................................................... 22 
Health  ............................................................................................... 23 
Malaria .............................................................................................. 24 
Rationale ..................................................................................................... 28 
Aim and objectives ............................................................................................ 30 
Overall aim ................................................................................................. 30 
Specific objectives ...................................................................................... 30 
Methods .............................................................................................................. 31 
Overall study design ................................................................................... 31 
Study settings and participants ................................................................... 32 
Study design, sampling and data collection ............................................... 33 
Study I  .................................................................................................................. 33 
Studies II & III .................................................................................. 34 
Sample size calculations (Studies I, II & III) ................................... 34 
Study IV ............................................................................................ 34 
Data management ....................................................................................... 35 
Data analysis ............................................................................................... 35 
Univariate, bivariate and multivariate analysis  
(Studies I, II & III) ............................................................................ 35 
Adherence definitions (Study I) ....................................................... 35 
System effectiveness analysis (Study II) ......................................... 35 
Equity analysis (Studies II & III) ..................................................... 36 
Deductive content analysis (Study IV) ............................................ 36 
Ethical considerations ................................................................................. 36 
Results ................................................................................................................ 37 
Adherence to ACTs (Study I) .................................................................... 37 
System effectiveness of a targeted free mass distribution of LLINs  
(Study II) ..................................................................................................... 38 
Effective coverage of vector control interventions (Studies II & III) ....... 39 
Bed-net usage patterns (Studies I, II & III) ............................................... 41 
Seasonality (Studies III & IV) .......................................................... 41 
Prioritizing children and bed-net sharing (Studies II, III & IV) ...... 41 
  
 
Caretaker perceptions on malaria and vector control   
(Studies II, III & IV) .................................................................................. 42 
Risk perceptions ............................................................................... 42 
Benefits and barriers ......................................................................... 43 
Sustainability .................................................................................... 44 
Discussion .......................................................................................................... 45 
Discussion of main findings ....................................................................... 45 
Vector control ................................................................................... 45 
Case management ............................................................................. 51 
Malaria elimination in Zanzibar ................................................................ 53 
Methodological considerations .................................................................. 55 
Study design ..................................................................................... 55 
External validity ............................................................................... 55 
Internal validity and reliability ......................................................... 56 
Ethical considerations....................................................................... 57 
Conclusions and Implications ........................................................................... 58 
Recommendations ...................................................................................... 59 
Acknowledgements ........................................................................................... 60 
References .......................................................................................................... 63 
 
 
 
 9 
 
LIST OF ABBREVIATIONS 
 
ACT 
AL 
Artemisinin-based Combination Therapy 
Artemether-Lumefantrine 
AMFm Affordable Medicines Facility - malaria 
AsAq Artesunate-Amodiaquine 
BCC Behavior Change Communication 
DDT Dichloro-diphenyl-trichloro-ethane 
DHMT District Health Management Team 
EIR Entomological Inoculation Rate 
GFATM Global Fund to fight AIDS, Tuberculosis and Malaria 
GMEP Global Malaria Eradication Program 
IEC Information, Education and Communication 
IMCI Integrated Management of Childhood Illnesses 
IPTi Intermittent Presumptive Treatment in infants 
IPTp Intermittent Presumptive Treatment in pregnant women 
IRS Indoor-residual Spraying 
ITN Insecticide-treated Nets 
LLIN Long-lasting Insecticidal Net 
MDG Millennium Development Goals 
MEEDS Malaria Early Epidemic Detection System 
MoH Ministry of Health 
PfPR Plasmodium falciparum Parasite Rate 
PHCC Primary Health Care Center 
PHCU Primary Health Care Unit 
PMI President's Malaria Initiative 
RBM Roll Back Malaria 
RDT Rapid Diagnostic Test 
RTI Research Triangle Institute  
SP Sulfadoxine-pyrimethamine 
SSA Sub-Saharan Africa 
USAID US Agency for International Development 
WHO World Health Organization 
ZAMRUKI Zanzibar Malaria Research Unit Karolinska Institutet 
ZMCP Zanzibar Malaria Control Program 
 10 
 
DEFINITIONS 
 
Malaria control: Reducing the disease burden to a level at which it is no longer a public 
health problem [1].  
 
Malaria elimination: Interruption of local mosquito-borne malaria transmission in a 
defined geographical area, i.e. zero incidence of locally contracted cases, although 
imported cases will continue to occur. Continued intervention measures are required 
[1]. 
 
Malaria eradication: Permanent reduction to zero of the worldwide incidence of 
malaria infection [1].  
 
Effective coverage: The proportion of the population in need of an intervention who are 
using an effective intervention (Paper II).  
 
System effectiveness: The accumulated proportion of success in all steps of an 
intervention (Paper II).  
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PREFACE 
 
I first came to Zanzibar in 1996, with the opportunity to live there for three months. It 
didn't take long for me to fall in love with the island. I loved its peaceful nature, the 
long beaches, the endless ocean, the narrow streets of stone town, the markets, the rich 
culture, the language, the music, the fruits, the spices, the calmness, the liveliness… 
and the people. What struck me the most about Zanzibar was the way in which people 
lived in such solidarity, as if they were one big family.  
 
I remember being amazed at the way mothers, when boarding a dala-dala (public 
transportation), would hand over their small children to any random person, who would 
seat the child on their lap or hold them, sometimes for the entire journey. No one 
refused this task and, although keeping very cool and calm, I could see that they were 
happy and honored to help. I also remember admiring the way that, on Fridays, the 
elderly people would go around the different shops and stands to collect money from 
the shopkeepers and vendors. Also here, no one ever refused to share the little they had. 
  
I returned to Zanzibar in 2005 for malaria research, and again I had the opportunity to 
live on the island. This time I was less naive, and I also became more aware of the 
difficulties and challenges. But despite the shortcomings, I have always felt so fortunate 
to be able to live and work in such a unique and wonderful place. Landing in ZNZ 
airport was always a breathtaking moment, not just because of the heat-wave that 
strikes you as you inhale that first breath of hot and humid air (), but because it 
always felt like coming back home.  
 
Mathematical models have assessed Zanzibar's ability to reach malaria elimination. The 
predictions are that it is possible, but extremely challenging. It will require decades of 
strong will and commitment to the cause. In addition to strong political commitment by 
the Zanzibar government and international partners, community participation was 
stressed as one of the vital condition for success. Here, Zanzibar has a secret advantage; 
the strong solidarity and team spirit that are inherent in the Zanzibari culture can and 
should be used to win this battle against malaria.  
 
 
 
As the Bongo Flava artists shout out to the crowd at the Old fort: 
 
Tuendelee ama tusiendelee 
(Shall we continue/carry on or not?) 
 
The crowd responds, together, united: 
 
Tuendelee 
(Let's continue/carry on) 
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BACKGROUND 
Malaria 
In 2010, 3.3 billion people worldwide were at risk of contracting malaria. The malaria 
burden has been difficult to estimate since most cases and deaths are never properly 
diagnosed and reported. However, revised estimates of the malaria burden indicate that 
there were approximately 216 million cases, and 655,000 deaths, due to malaria in 
2010. These figures remain high, despite the 26% reduction in mortality and 17% 
reduction in morbidity and incidences per population at risk in the past decade. The 
burden is highest in the African region, where 81% of cases and 91% of malaria deaths 
occur, with children under five years of age and pregnant women being the most 
vulnerable [2].   
 
Malaria is a parasitic disease caused by the protozoan Plasmodium. There are five 
species that cause human malaria: P. falciparum, P. malariae, P. ovale, P. vivax and P. 
knowlesi. P. falciparum is the most common species in Sub-Saharan Africa (SSA) and 
is also the most pathogenic species, responsible for the majority of malaria deaths. The 
vector is a female Anopheles mosquito, and there are over 30 Anopheles species that are 
able to transmit Plasmodium [2, 3]. 
 
Plasmodium has a complex life-cycle that takes place in both the vector and the human 
host. During a blood meal, the mosquito takes up female and male Plasmodium 
gametocytes from an infected human host. The gametocytes create zygotes in the 
mosquito gut. The zygotes develop into oocysts that, in turn, form sporozoites which 
migrate to the salivary glands. When the mosquito takes another blood meal, she 
inoculates another human with the sporozoites. The sporozoites travel through the 
human blood stream into the liver cells where they multiply and are again released into 
the blood as merozoites. In the blood stage, the merozoites attack red blood cells and 
transform into trophozoites. The trophozoites then multiply into merozoite cells within 
a blood cell, until it bursts and the released merozoites continue to infect more blood 
cells. During the blood stage some merozoites develop into female and male 
gametocytes, which the mosquito again takes up during a blood meal [4]. 
 
In P. falciparum infections, the symptoms usually appear 9-14 days after being bitten 
by an infected mosquito, when the parasites are in the blood stage. Symptoms of 
uncomplicated malaria include fever, headache, vomiting and other flu-like 
symptoms. If the infection is not treated promptly, severe forms of malaria may 
develop. These include conditions such as severe anemia and, the most life-
threatening complication, cerebral malaria [3]. 
 
Epidemiology 
Malaria endemicity has historically been classified by splenomegaly (enlargement of 
the spleen) or parasitemia rates as follows: over 75% is holo-endemic; 51-75% is 
hyper-endemic; 11-50% is mesoendemic; and 10% or less is hypoendemic [3].  
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Another classification of P. falciparum endemicity is by P. falciparum parasite rate 
(PfPR) and P. falciparum annual parasite incidence (PfAPI) [5] (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The Spatial distribution of Plasmodium  
falciparum malaria PfPR2-10 in 2010 stratified by  
endemicity class 
 
Source: Gething et al. Malaria Journal 2011, 10:378 [5] 
 
 
An additional classification is vector-based and relies on the entomological 
inoculation rate (EIR), i.e. the number of infected bites per person per year. 
According to this classification, when malaria is stable, the population is continuously 
exposed to a high rate of malaria inoculations, with an EIR of over 10 per person per 
year. Un-stable malaria is characterized by fluctuating inoculation rates over seasons 
and years, with EIRs usually between 1 to 5 per person per year [6].  
 
Malaria transmission, or the spread of malaria, is measured by the basic reproduction 
rate. This is the number of new malaria cases generated by a single case. Reproduction 
rate is an expression of the efficiency of the mosquito vector (vectorial capacity) and 
the magnitude of infective parasite pool in humans [1].  
 
In high transmission settings, the population develops acquired immunity after being 
exposed to Plasmodium several times. In these areas, the vulnerable groups are 
children under the age of five who have not developed immunity yet, and pregnant 
women whose immunity is compromised [7]. 
 
Malaria control 
Case management 
Malaria control highly relies on early diagnosis and prompt appropriate treatment, 
within 24 hours of onset of symptoms. This is crucial because although 
uncomplicated malaria is easily curable with efficacious drugs, delaying treatment, 
especially in vulnerable groups such as children, may lead to severe forms of malaria. 
Case fatality rates for children hospitalized with severe malaria are 10-50% [3].  
Malaria free  
PfAPI < 0.1%  
0% < PfPR≤ 5%  
5% < PfPR < 40%  
PfPR ≥ 40%  
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The gold standard for malaria diagnosis has been microscopy. A blood drop taken 
from the patient's finger is smeared on a slide, and Giemsa staining is then used to 
highlight the parasite and make it more visible under the microscope. However, due 
to weak health systems and inadequate facilities in resource-poor settings, most 
malaria diagnoses have been presumptive and rely solely on symptoms. Integrated 
Management of Childhood Illnesses (IMCI) is a simple tool developed by the World 
Health Organization (WHO) which is designed to improve management of childhood 
illnesses in resource-poor settings. Since the most common symptom of malaria is 
fever, IMCI guidelines state that all febrile cases in malarious areas should be treated 
with antimalarials [8]. More recent developments in diagnosis are the rapid diagnostic 
tests (RDTs) which are based on antigen detection. Blood from a finger prick is 
placed in a plastic cassette and spreads on a filter paper with an antibody strip that 
changes its color if antigens adhere to it. The recent scale-up of RDTs has made 
malaria diagnosis easier and more accessible, and it is now recommended that malaria 
diagnosis, using either microscopy or RDTs, should always precede treatment with 
antimalarials [6]. However, there have been concerns about the validity and reliability 
of RDTs. For example, antigens can stay in the blood up to two weeks after infection 
and thus give a false-positive result. An additional concern is the cost-effectiveness of 
using RDTs, especially in high-transmission areas.    
 
For several decades, treatment of uncomplicated malaria has relied on two inexpensive 
and widespread drugs, namely chloroquine and Sulfadoxine-pyrimethamine (SP). 
However, the abundance of these drugs and their misuse has led to resistance [9]. The 
first evidence of chloroquine-resistant P. falciparum in Africa arose in 1979, and by the 
late 80s reports of resistance were extensive, with drug failure rates varying between 
10% and 90% [10]. However, it was only in the late 90s that the harsh implications of 
antimalarial resistance were realized and this was followed by an outcry within the 
scientific community [11, 12]. Antimalarial resistance had a major public health impact 
in SSA with a notable increase in malaria cases and deaths. Most affected were young 
children under the age of five, and in the 90s malaria-specific mortality rose in this age 
group [13-15], accounting for approximately a third of all under-five deaths [13]. Other 
negative effects of resistance included the increase of other related health conditions 
such as anemia [16], an increased burden on the health systems, as well as social and 
economic consequences [17].        
 
Artemisinin-based combination therapies (ACTs) were identified as the most 
appropriate replacement for treatment of uncomplicated malaria, and have been 
recommended by WHO since 2001 [18, 19]. Artemisinin and its derivatives are highly 
efficacious, leading to rapid reduction of the parasite (including reduction of 
gametocytes) and resolution of clinical symptoms, with few adverse events and with 
no reported resistance at that time [11, 18]. The purpose of combining artemisinin 
derivatives with a partner drug was to prevent the emergence of resistance. 
Additionally, combination with a drug that has a longer half-life ensured shorter dose 
regimens with higher cure rates and less possibility for recrudescence [11].  
 
The two most used ACT combinations in SSA are either Artemether-Lumefantrine 
(AL) or Artesunate-Amodiaquine (AsAq). AL is currently adopted as the first-line 
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antimalarial by 22 malaria endemic countries and AsAq is the first line treatment in 
13 countries, while 9 countries are using both [20].  
 
Prevention 
Malaria prevention mostly relies on vector control interventions; mainly bed-nets and 
indoor-residual spraying (IRS). Bed-nets have been used in different cultures since 
ancient times to protect against insect bites [21]. They are especially useful in 
preventing malaria due to the fact that Anopheles mosquitoes are active from dusk till 
dawn. Thus, a physical barrier that protects people when they sleep is an effective way 
to prevent malaria. In the past two decades there has been renewed interest in bed-nets 
and especially in insecticide-treated nets (ITNs) which were revitalized in the mid 80s. 
In addition to the physical barrier, the insecticide repels, inhibits or kills the mosquitoes 
and thus provides not only a better individual protection to those sleeping under the net, 
but also have a community effect [7]. Insecticide-treated nets have been found to be 
efficacious, and in randomized control trials they reduced overall under-five mortality 
by 18% [22]. Despite the worry that the high ITN efficacy would not be translated into 
effectiveness under routine conditions [23], it has been show that the scale-up of ITNs 
result in 23-27% reduction in child mortality [24-26]. 
 
WHO started recommending and endorsing ITNs as the leading malaria prevention 
intervention in the late 90s [27]. However, due to low re-treatment rates of ITNs, the 
long-lasting insecticidal nets (LLINs) were developed [28]. LLINs do not require 
treatment or re-treatment by the consumer, as they are pre-treated in the factory with an 
insecticide that is embedded in the fabric and can remain effective for 4-5 years. ITNs 
and LLINs are normally treated with pyrethroids [29].  
 
In 2006, the WHO also started recommending the scale-up of IRS as an additional 
control intervention [30]. IRS is the application of residual insecticides on the inner 
walls and roofs of dwellings, where many of the Anopheles species tend to rest after 
taking a blood meal [2, 30]. Although there is a general lack of evidence on the health 
impact of IRS from formal trials, especially in stable malaria settings [31], IRS with 
dichloro-diphenyl-trichloro-ethane (DDT) was the main vector control strategy in the 
1940s-60s and was responsible for malaria elimination in many unstable transmission 
areas. Today, in addition to DDT, other insecticides used for IRS belong to 3 
chemical groups: pyrethroids, organophosphates and carbamates [30].     
 
Although ITNs seem to be more effective than IRS in areas with high endemicity [32-
34], both interventions are often scaled up simultaneously. Combining IRS and ITN 
has previously shown to have an additive effect [35, 36]. However, achieving an 
additive effect is thought to be highly dependent on the insecticides used, coverage 
and vector characteristics [37].  
 
Additional vector control interventions, such as larva control in breeding water 
bodies, fogging or area spraying and environmental management, are also available. 
Though they are not being scaled up, they are still used to some extent, especially in 
densely populated urban settings [38].  
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Other prevention interventions include preventive therapies for malaria. Intermittent 
presumptive treatment for pregnant women (IPTp) is the most widespread 
intervention of this type. With IPTp, all pregnant women in malaria endemic areas are 
provided with at least 2 doses of malaria treatment during their pregnancy. IPT can 
also be given to infants (IPTi), although this intervention has not been adopted as 
national policy and scaled up as of yet [2]. Seasonal malaria chemoprevention (SMC) 
is now also being considered in areas with seasonal transmission [2].  
 
History of malaria control 
Malaria was historically controlled mainly through environmental management even 
prior to the discovery of the malaria transmission mechanisms in the end of the 19
th
 
century. Later, the development of the residual insecticide DDT in the 1940s and the 
growing evidence of its effectiveness prompted the initiation of the Global Malaria 
Eradication Program (GMEP) [39].   
 
When the GMEP was initiated by the WHO in 1955, eradication efforts focused on IRS 
with DDT, antimalarial treatment with chloroquine, and surveillance. While the 
program had succeeded in eliminating malaria from areas with temperate climates and 
seasonal malaria transmission, such as Europe and North America, there were no major 
successes in areas with tropical climate and high and stable transmission, such as in 
SSA. The failure was attributed to several reasons, and especially to technical 
challenges and the development of resistance to DDT. Thus, the program was finally 
abandoned in 1969 [39, 40]. 
 
In the post-eradication era, during the 1970s-90s, there was little global support for 
malaria control. However, a better understanding of the social, economic and cultural 
dimensions of malaria was achieved, and advances were made on malaria control tools 
such as ITNs. With the realization that there was no "magic bullet" for malaria control, 
an integrated approach which included the combination of several interventions, was 
adopted. The goals became less ambitious, and instead of eradication the new aim was 
for malaria control [40].  
 
Despite the overall reduction in child mortality during the 1980s and 1990s in most 
regions of the world, malaria specific mortality increased in Africa. The increase was 
largely due to drug resistance, emerging resistance to insecticides used for vector 
control and the general deterioration of primary health services [41]. This led to a 
renewed global focus on malaria, and in 1992 malaria was re-established as a global 
health priority at the Conference of Ministers of Health in Amsterdam, and in 1993 
WHO started formulating a global strategy for malaria control [42, 43].    
 
In 1998, the Roll Back Malaria partnership (RBM) was launched with the goal of 
halving the global burden of malaria by 2010, and  by 75% by 2015 [44] (Table 1). In 
2000, African heads of state signed the Abuja declaration, where they committed 
themselves to the RBM goal through implementation of several strategies including 
prompt access to effective treatment, prevention with ITNs, prevention and control in 
pregnant women and strengthening the malaria epidemic and emergency response [7, 
45]. 
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Global financial support for up-scaling malaria control interventions were made 
available through the initiation of several organizations, including: Global Fund to fight 
AIDS, Tuberculosis and Malaria (GFATM) in 2002; The US President's Malaria 
Initiative (PMI) in 2005; and the World Bank's Booster Program for Malaria Control in 
Africa in 2005.   
 
Due to the recent advances in malaria control in SSA, malaria elimination and even 
eradication is again "back on the table" following a plea by Bill and Malinda Gates [1, 
40, 46, 47]. The Global Malaria Action Plan (GMAP), formulated in 2008 by RBM, 
explicitly mentions eradication as a long-term target [48]. The GMAP provides a 
guideline on how to achieve elimination by first controlling malaria through scaling-up 
for impact (SUFI) of interventions and then sustaining control over time to prevent its 
resurgence. In areas of stable high transmission a "consolidation period" should be 
introduced, where achievements are sustained, health services adapt to the new clinical 
and epidemiological situation, and surveillance systems are strengthened. When the 
incidence rate is decreased to five or less new cases per 1000 population at risk per year 
(with the proxy measure of having a monthly slide positivity rate of less than 5% in 
febrile cases), the low case load allows intensive follow-up of new cases which is 
required by an elimination program. At this stage, the country can start the pre-
elimination phase, and move into the elimination phase when incidence rates are below 
1 per 1000 population at risk per year. After reaching elimination, measures should 
continue to be in place to prevent re-establishment of transmission [1, 48]. The steps 
from control to elimination are illustrated in Figure 2. 
 
The Millennium Development Goals (MDGs), which were initiated after the 
Millennium Summit in 2000, have been used to guide strategic plans in low and middle 
income countries. The RBM global strategic plan 2005-2015 states that "Six out of 
eight Millennium Development Goals can only be reached with effective malaria 
control in place" [49]. This is due to malaria's direct and indirect associations with child 
mortality, maternal health, poverty, education and access to antimalarials, in addition to 
the malaria-specific target (MDG 6c) of halting and beginning to reverse the incidence 
of malaria by 2015 (Table 1) [49, 50].  
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Table 1: Goals and targets for malaria control 
 
Targets for 2005 Targets for 2010 Targets for 2015 
  
Reduce global malaria deaths from 2000 
levels by 50% [48] 
 
Reduce global malaria cases from 2000 
levels by 50% [48] 
 
 
Reduce global malaria deaths to near zero 
[51] 
 
Reduce global malaria deaths from 2000 
levels by 75% [52] 
 
Reduce global malaria cases from 2000 
levels by 75% [51, 52] 
 
MDG 6: Have halted and begun to reverse 
the incidence of malaria and other major 
diseases [53] 
   
 
At least 60% of those at risk of malaria 
particularly pregnant women and children 
under five years of age, benefit from the 
most suitable combination of personal and 
community protective measures [45] 
 
At least 60% of all pregnant women who 
are at risk of malaria, especially those in 
their first pregnancies, have access to 
chemoprophylaxis or presumptive 
intermittent treatment  [45] 
 
 
Achieve universal coverage for all 
populations at risk of malaria using locally 
appropriate interventions for prevention 
and case management [48] 
 
80% of people at risk from malaria are 
protected, thanks to locally appropriate 
vector control methods such as insecticide-
treated nets (ITNs), and, where 
appropriate, indoor residual spraying (IRS) 
and, in some settings, other  environmental 
and biological measures [49, 52] 
 
At least 80% of pregnant women receive 
intermittent preventive treatment in areas 
where malaria transmission is stable [49, 
52] 
 
 
Achieve universal access to and utilization 
of prevention measures: By end 2013, in 
countries where universal access and 
utilization have not yet been achieved, 
achieve 100% access to and utilization of 
prevention measures for all populations at 
risk with locally appropriate interventions 
[51] 
 
Sustain universal access to and utilization 
of prevention measures: By 2015 and 
beyond, all countries sustain universal 
access to and utilization of an appropriate 
package of preventive interventions [51] 
 
 
At least 60% of those suffering from 
malaria have prompt access to and are 
able to use correct, affordable and 
appropriate treatment within 24 hours of 
the onset of symptoms [45] 
 
 
80% of malaria patients are diagnosed and 
treated with effective antimalarial 
medicines, e.g. artemisinin-based 
combination therapy (ACT) within one day 
of the onset of illness [49, 52] 
 
Achieve universal access to case 
management in the public sector: By end 
2013, 100% of suspected cases receive a 
malaria diagnostic test and 100% of 
confirmed cases receive treatment with 
appropriate and effective antimalarial drugs 
[51] 
 
Achieve universal access to case 
management, or appropriate referral, in the 
private sector: By end 2015, 100% of 
suspected cases receive a malaria 
diagnostic test and 100% of confirmed 
cases receive treatment with appropriate 
and effective antimalarial drugs [51] 
 
Achieve universal access to community 
case management (CCM) of malaria: By 
end 2015, in countries where CCM of 
malaria is an appropriate strategy, 100% of 
fever (suspected) cases receive a malaria 
diagnostic test and 100% of confirmed 
uncomplicated cases receive treatment 
with appropriate and effective antimalarial 
drugs, and 100% of suspected and 
confirmed severe cases receive 
appropriate referral [51] 
 
   
Accelerate development of surveillance 
systems: By end 2015, all districts are 
capable of reporting monthly numbers of 
suspected malaria cases, number of cases 
from all public health facilities, or a 
consistent sample of them [51] 
 
 
Source: WHO World Malaria Report 2011 [2] 
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Figure 2: Epidemiological milestones from control to elimination 
Source: The Global Malaria Action Plan, 2008 [48] 
 
 
Although malaria control programs have usually been vertical "stand-alone" initiatives 
[54], it has increasingly been recognized that malaria control efforts should be 
integrated and coordinated with other health activities within the existing health 
systems [40]. Thus, there is now more emphasis on general health system strengthening 
and capacity building, in addition to implementation of malaria-specific interventions 
[48, 49]. 
 
From efficacy to effectiveness 
Highly efficacious control interventions are available to combat malaria. Efficacy 
describes the effect of an intervention under optimal conditions, such as those achieved 
under randomized control trials. Effectiveness in real-life conditions, also known as 
"community effectiveness", is often considerably lower due to different barriers. The 
steps from efficacy to "community effectiveness" could include: access, diagnostic 
accuracy, provider compliance and consumer adherence [55, 56].  
 
Efficacy 
Malaria control currently relies heavily on a limited number of efficacious tools, in 
particular artemisinin derivatives for therapy and pyrethroids for vector control. 
However, their high efficacy is threatened by development of parasite and vector 
resistance [1, 2], especially in light of their wide-spread use.  
 
Emergence and increase of P. falciparum artemisinin resistance has been identified at 
the Cambodia-Thailand border from 2002 [57, 58]. Evidence of resistance has so far 
been constrained to limited areas in Southeast Asia [59]. In 2011, the WHO released 
the Global Plan for Artemisinin Resistance Containment (GPARC), with the aim of 
halting the spread of resistance [59].  
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Pyrethroids are now the most commonly used insecticides for ITNs and LLINs. It is 
also one of the insecticides used for IRS. Resistance to pyrethroids is emerging in SSA 
[60, 61], compromising the efficacy of vector control interventions.  
 
Given the above, research and development of new highly efficacious antimalarials and 
insecticides to replace current tools that will inevitably become resistant are major 
necessities. These new agents should ideally be from new classes, and different agents 
with different modes of action should be combined to delay development of resistance 
[1]. Although maintaining efficacy is crucial, this thesis will focus on the 
implementation of currently available efficacious tools. 
 
Access 
Access to timely and appropriate treatment can be hampered by many different factors 
inside and outside the home. When a child is sick, the immediate caretaker, usually the 
mother, is responsible for recognizing the illness and seeking care. Health-seeking 
behavior is complex and is influenced by geographical, financial and cultural factors. 
Mothers' low access to financial resources and lack of decision making power is often 
an obstacle for timely treatment-seeking [62-64]. Local beliefs and disease perceptions 
often drive the choice of treatment, be it biomedical ("western") or traditional medicine 
[65, 66].  
 
When biomedical treatment is chosen, the type of facility, whether it is a public health 
facility, private health facility, pharmacy or normal shop, will greatly affect the access 
to appropriate drugs. The high cost of ACTs may influence their accessibility, 
especially in the private health sector. In public health facilities, even if ACTs are the 
antimalarial of choice, they might not be available due to stock-outs. At the health 
facility level, diagnostic accuracy and provider compliance to national guidelines, 
which was often observed to be low [67, 68], may further reduce the patient's access to 
an efficacious treatment.  
 
Access to ITNs and IRS is largely influenced by health system delivery strategies. 
While IRS has been implemented through the public health sector and provided free of 
charge, there has been debate as to which delivery system is most efficient in scaling up 
("catch-up") and sustaining ("keep-up") ITN coverage [69, 70]. Available strategies 
range from social marketing [71] and voucher schemes [72], to free mass distributions 
[73]. 
 
Socio-economic inequity is also an important factor which hampers access. Access to 
good medical care or preventive measures tends to vary inversely with the need of the 
population served [74]. Thus, the poor, who are often more exposed to mosquitoes 
and malaria, are often less likely to access anti-malarial treatment [75] and to own or 
use bed-nets [7, 76, 77]. 
 
Adherence  
Adherence can be influenced by attitudes and beliefs, as well as social, economic and 
emotional factors. In an attempt to better understand health-related behavior and the 
determinants of adherence to health interventions, a number of theoretical models have 
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been proposed, including the Health Belief Model (HBM) which is widely used. The 
HBM states that individuals will take a health related action to prevent, diagnose or 
treat a health condition if they have a desire to avoid an illness or get well and if they 
believe that a specific health action will, in fact, prevent the illness or improve their 
condition. The model includes six elements: 1) Perceived susceptibility of the 
individual to the condition; 2) perceived severity of the condition as having serious 
medical and social consequences; 3) perceived benefits of taking the health action in 
reducing the disease threat as well as other additional benefits; 4) perceived barriers to 
taking the health action, which should not overweigh the benefits. These four 
perceptions are elements that determine the readiness to take action. They are activated 
by: 5) Cues to action that trigger readiness and 6) self efficacy, which is the conviction 
that one can successfully execute the health behavior. Although the HBM is one of the 
most widely used models, it has been criticized for solely focusing on individuals' 
attitudes and beliefs without taking into account other factors that may also influence 
health-related actions. Additionally, there is dispute as to which of the HBM 
components have more influence on health-behavior and what the relationship is 
between these components [78, 79]. 
 
Adherence to ACTs is vital, since non-completion of the standard regimens can result 
in treatment failure and promote resistance development [80, 81]. Ensuring consumer 
adherence is important since most antimalarials for uncomplicated malaria are 
administered at home. Previous studies on adherence to a full treatment course of 
ACTs have shown varying results, ranging from 39% to 97% [82, 83]. Factors found 
to influence adherence to antimalarials include education level [84-86], drug 
packaging and dosing [87, 88], speed of symptom relief [89], duration of treatment 
[89, 90] and communication with the health worker [84, 91, 92]. 
 
Adherence to ITNs is also crucial in maintaining its effectiveness since it is up to 
community members to cover themselves and their children with bed-nets every 
night. ITN adherence was previously shown to vary by seasonality [93, 94], age [94, 
95] and gender [96, 97]. Education of the head of the household was found to affect 
adherence in Nigeria, but not in Kenya [94, 98]. Non-adherence due to disruption of 
sleeping arrangements, temporary migrations and difficulties in mounting the nets 
was reported [94, 99-101]. Fear of toxicity and safety of ITNs, which was mentioned 
in early distributions, were reduced with time [97, 99]. Partial effectiveness of the 
nets, due to perceived additional causes of malaria, as well as use of other protective 
measures against malaria was also found to impede adherence to bed-nets [97, 99, 
102]. However, perceived additional advantages of bed-nets, such as providing 
protection against mosquitoes and other insects and pests, was found to uphold their 
use [99, 100]. 
 
IRS, on the other hand, does not require continuous adherence from community 
members after the initial agreement to have the house sprayed. Community acceptance 
of IRS was previously impeded by increase in bedbug infestation, insecticide smell, 
mess left by the sprayers, inconvenience of having to remove furniture from the house, 
perceived ineffectiveness and side effects [103-105]. Additionally, effectiveness can be 
reduced by re-plastering and washing the walls after they have been sprayed [104, 106].  
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System effectiveness and effective coverage 
System effectiveness and effective coverage are both outcomes that describe how well 
an intervention had been implemented. Although there are different definitions for 
these terms in the literature [107-109], in this thesis, the following definitions are used:  
 
Effective coverage: The proportion of the population in need of an intervention who are 
using an effective intervention. 
 
System effectiveness: The accumulated proportion of success in all steps of 
implementing an intervention. 
 
Both system effectiveness and effective coverage are relevant outcomes in assessing 
the overall success of an intervention implementation, and both outcomes encompass, 
and are influenced by, programmatic issues that affect access as well as caretakers' 
adherence to the intervention. While each step of the implementation must be measured 
and accumulated in order to compute system effectiveness, effective coverage can more 
easily be evaluated by measuring the final outcome of the implementation, regardless 
of success rates in each step. Thus, system effectiveness and effective coverage 
measure the effectiveness of the implementation of an intervention rather than the 
effectiveness of the intervention itself.  
 
Zanzibar 
Zanzibar is an archipelago off the coast of mainland Tanzania. It was united with 
Tanganyika in 1964 to form the United Republic of Tanzania. However, Zanzibar 
remains semi-autonomous and has its own government, the Revolutionary 
Government of Zanzibar. Zanzibar consists of two large islands, Unguja and Pemba, 
and numerous small islands. Unguja is approximately 1,464 km
2 
and Pemba is 
smaller with 864 km
2
. Zanzibar is divided into 5 regions and 10 districts; 6 in Unguja 
and 4 in Pemba. The districts are sub-divided into constituencies and shehias. A 
shehia is the smallest administrative unit and is composed of several communities or 
villages, and is led by a Sheha [110].  
 
The projected total population of Zanzibar in 2011 was over 1.3 million with 
approximately 64% in Unguja and 36% in Pemba Island. The under-five children 
comprise around 18% of the total population [111]. Approximately 60% of the 
population is rural and the main livelihood is subsistence farming and fishing. In 
2002, the annual population growth rate was 3.1% [112], and in 2010 the population 
density was more than 10 times greater than on Tanzania's mainland, with 518 
persons per km2 [113]. The literacy rate in 2002 was around 73%. The population is 
mostly Muslim and the spoken language is Kiswahili.  
 
The climate is tropical and humid, with two distinct rainy seasons; the long or heavy 
rains (Masika) from March/April to May/June and the short rains (Vuli) from October 
to December. There is also a seasonal classification by temperature, whereby the cool 
season occurs between June and November and the hot season occurs between 
December and March. 
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Health 
Zanzibar's Ministry of Health (MoH) is under the direct jurisdiction of the Zanzibar 
government and is independent from the Tanzanian Ministry of Health. The MoH 
provides free health care through public health facilities. Health services are also 
provided through the private sector, which is largely concentrated in the urban areas 
and include hospitals, clinics pharmacies and "over the counter" drug shops. In addition 
to the for-profit facilities, there are not-for-profit and non-governmental organizations 
as well [110].  
 
The public health system in Zanzibar is provided at three levels. The primary level 
includes 1
st
 and 2
nd
 line primary health care units (PHCU and PHCU+) that provide 
outpatient services, and primary health care centers (PHCCs), also known as "cottage 
hospitals", which provide basic inpatient services. The primary health facilities should 
have at least one staff member providing out-patient services (medical assistant or 
nurse practitioner A), at least one staff member providing reproductive and child health 
services (midwife or public health nurse B) and a health promotion person 
(environmental health officer). Some also have a laboratory technician and a 
pharmaceutical assistant that dispenses medicines. The secondary level includes district 
hospitals that serve as referral points for primary level facilities. The tertiary level 
includes the referral hospital Mnazi Mmoja which is located on Unguja Island. Mnazi 
Mmoja also has two specialized wings for maternity and mental health [110].  
 
Overall, there are more than 130 PHCUs, four PHCCs and four hospitals in Zanzibar, 
resulting in high geographical access whereby over 95% of the population is living 
within five kilometers of a health facility [110]. However, population density is high, 
and although population coverage per health facility should ideally be between 4,000-
8,000 people it is sometimes up to 4-folds higher, especially in the Urban and West 
districts (personal communication with Sharifa Awadh Salmin, GF portfolio 
Coordination –ZMCP, 2012). This, in addition to financial constraints and shortage of 
human resources, which hampers the quality of health services on the one hand, and the 
high infectious diseases burden on the other, has resulted in generally poor health of the 
population [110, 114] (Table 2). 
 
Table 2: Zanzibar health indicators 
 
      2002  2010 
Life expectancy      57 years
*
 59.5 years
** 
Total fertility rate       6.2
*
 5.1
*** 
Infant mortality rate  
per 1,000 live births 
     89
*
 54
*** 
Under-five mortality rate  
per 1,000 live births  
     141
*
 73
*** 
 
Sources:
  *
 2002 census: Analytical report [112] 
** 
Tanzania in Figures 2010 [113] 
***
 Tanzania Demographic and Health Survey [115] 
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In 2001 the MoH started the health sector reform which aimed at improving health and 
well being, especially of vulnerable groups including children. To achieve this aim, 
structural and management changes with emphasis on decentralization are taking place. 
Two Zonal Health Offices, one in Unguja and one in Pemba island, are meant to serve 
as a link between the districts and the MoH headquarters, and are responsible for 
supervising and monitoring the health services and the channeling of operational 
funding to the districts within their zones. On the district level, the District Health 
Management Teams (DHMTs) are responsible for planning and management of health 
care services provided in their respective districts. An additional organizational goal of 
the health sector reform is to integrate the different vertical programs. The Zanzibar 
Malaria Control Program (ZMCP) is one of these vertical programs, which functions 
under the director of preventive services and health education [110, 114].  
 
The MoH also aims to improve access to high quality health care services, with 
emphasis on primary care. This is done by reducing the patient crowding through 
increasing human resources and out-patient services as well as introducing community 
level health workers that will assist the health facilities, especially with health 
education. On the referral level, existing PHCC and district hospitals will be upgraded.  
 
Malaria 
The main malaria vectors on Zanzibar belong to the Anopheles gambiae complex. 
Plasmodium falciparum is the predominant malaria species which constitutes over 95% 
of all malaria infections, while less than 5% are due to Plasmodium malariae [116]. 
 
Historically, Zanzibar was classified as an area with high and stable malaria 
transmission. In the mid 20s till mid 50s, malaria prevalence was as high as 68%, 
despite control efforts which included environmental management, chemical and 
biological larviciding, quinine distribution and the use of mosquito nets [117].   
 
Zanzibar attempted malaria elimination twice. It was one of the areas that achieved 
satisfactory malaria reduction during the GMEP, using IRS and mass drug distributions 
[118]. By the late 1960s malaria transmission was low, and malaria prevalence was 
below 5%, but interrupted transmission was not achieved due to technical and 
operational problems. Within a few years after the GMEP was abandoned, the malaria 
burden increased again, and reached prevalence rates of 40% in the late 1970s. The 
second attempt was the Zanzibar Malaria Control Project, which was an aggressive 
program led by the US Agency for International Development (USAID) in 1984-1989. 
Strategies included IRS and chloroquine administration. However, this program was 
also not successful, and malaria re-emerged once more [117, 119]. 
 
Although the malaria burden in Zanzibar did not return to its historical hyper-
holoendemicity, it was still considered to have high and stable transmission, with peaks 
during and right after the rainy seasons. In 2001, malaria was the most common illness 
in Zanzibar, constituting more than 40% of all diagnoses at the health facilities and was 
the leading cause of morbidity and mortality [120]. However, with the renewed fight 
against malaria, and with heavy reliance on external funding, Zanzibar has made 
enormous advances through case management and preventive interventions. 
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Case management 
In 2000 it was established that the therapeutic efficacy of chloroquine had been 
grossly reduced in Zanzibar and the treatment failure rates exceeded 60% [120]. As a 
result, Zanzibar was one of the first nations in Africa to change their malaria 
treatment policy to ACTs in May 2002. Zanzibar opted for AsAq combination for 1
st
 
line treatment and AL as 2
nd
 line treatment of uncomplicated malaria. Quinine was 
the 3
rd
 line treatment and drug of choice for severe malaria. SP was recommended for 
IPTp and treatment of uncomplicated malaria in pregnancy [120].  
 
ACTs were deployed to all public health facilities by May 2003, where they were to 
be given free of charge to all malaria diagnosed patients. Until 2006, the artesunate 
and amodiaquine pills were dispensed in four different dose-specific sachets for the 
different age-groups (<1 year, 1-6 years, 7-13 years, >14 years). From 2006 to 2010, 
the AsAq was dispensed in the form of a co-blistered package (Falmal
®
) (Cipla Ltd., 
India), which had 2 packs; one for "children" (0-6 years) and one for "adults" (over 7 
years) [121]. The children pack consisted of 3 tablets of As (50 mg) and 3 tablets of 
Aq (100 mg) and included two dose regimens; the "infant dose" for children under 1 
year or weighing under 10 kg and the "child dose" for children between one and six 
years or weighing 10-20 kg. In 2010, co-formulated AsAq tablets, which came in four 
dose-specific packs, was adopted. 
 
New national guidelines for malaria diagnosis and treatment were introduced in 2010, 
the 1
st
 line drug remaining AsAq while AL was an alternative drug in case of 
intolerance, and parenteral quinine remained the preferred drug for severe malaria, 
followed by ACTs for completion of treatment. SP is still recommended for IPTp, 
however treatment for uncomplicated malaria in pregnancy in the 1
st
 trimester is now 
oral quinine, while AsAq is used in the 2
nd
 and 3
rd
 trimesters  [122].  
 
Although ACTs have been dispensed free of charge in the public sector, they were 
expensive and largely unavailable in the private sector until 2010, when Zanzibar, 
together with Tanzania, was chosen for the pilot phase of Affordable Medicines 
Facility - malaria (AMFm), that provide subsidised ACTs at an affordable cost [123]. 
 
Diagnostics were scaled-up in 2006 and currently every public health facility has 
RDTs (82%), microscopes (4%), or both (14%). Initially, the Paracheck
®
 RDTs, 
which only detect P.falciparum, were deployed. However, they have now been 
replaced by SD Bioline
®
 RDTs that can detect all Plasmodium species. ACTs and 
RDTs are funded through GFATM and PMI.  
 
Prevention 
Malaria prevention in Zanzibar, as in most SSA countries, relies mainly on vector 
control and prevention in pregnancy. The ZMCP started information, education and 
communication (IEC) activities regarding bed-nets in the early 90s. A cost recovery 
scheme was implemented from 2003 to 2005, whereby nets provided by UNICEF 
were sold at a reduced price at antenatal clinics. Other efforts included small scale 
social marketing efforts and re-treatment campaigns. However, coverage remained 
low, and in May 2005 the overall ITN use in children under five in Zanzibar was 
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documented at 40%, with Micheweni district having the lowest under-five ITN use of 
less than 10% [124]. As a result, retreatment campaigns were carried out in 
Micheweni district during 2005, and continued being carried out sporadically in 
different districts till 2009. 
 
Additionally, the GFATM and PMI supported the ZMCP in carrying out a targeted 
free mass distribution of LLINs to all pregnant women and children under five. The 
campaign took place from August 2005 till February 2006 in nine of the 10 districts 
of Zanzibar (excluding the Urban district). The distributed nets were blue rectangular 
Olyset® nets, which were made of polyethylene and had a mesh size of 4×4 mm. 
Micheweni district was chosen as the site for trial implementation in August 2005. 
The distribution scale-up in the other districts followed in January 2006. For details 
on the 2005-2006 distribution see the Methods section in Paper II. 
 
After the mass distribution, there was an attempt to start up a voucher system through 
antenatal clinics, whereby pregnant women could purchase LLINs at a reduced price. 
This attempt was unsuccessful and was terminated within a few months. Since 2009, 
UNICEF has been providing PermaNet® LLINs for free distribution in antenatal 
clinics; however these provisions are not consistent and rely on irregular availability of 
nets. 
 
The second free mass distribution of LLINs took place from 2008 till 2009 in seven out 
of the 10 districts, as well as in some shehias of the Urban district. In this distribution 
all households were to receive two LLINs, except for households with a single resident, 
who received only one LLIN. The majority of LLINs that were distributed were the 
same blue rectangular Olyset® nets which were distributed in 2006, but some were 
white PermaNet® LLINs that cannot be easily distinguished from conventional nets. 
The LLINs supply was funded by GFATM.   
 
A third mass distribution, the Zanzibar universal coverage campaign, took place in 
2012. In this distribution, all households of all districts received one to three nets per 
household, according to the universal coverage method of one net for every two people. 
For this distribution, Olyset® nets were donated by the UK Department for 
International Development (DIFID), while Yorkool® LLINs were funded by GFATM. 
The distribution was carried out with technical support from the Red Cross. 
 
IRS rounds started in 2006 with support from PMI and the Research Triangle Institute 
(RTI). Three biannual rounds with the synthetic pyrethroid lambda-cyhalothrin (ICON) 
were implemented in 2006-2007. In December 2008 an ICON formulation, with a 
residual effect that ranges between 9-12 months, was used, followed by two rounds in 
March 2010 and January 2011. The rounds included all districts of Zanzibar but 
excluded houses in Stone Town. Due to indications of Anopheles resistance to 
pyretheroids in 2011, in the spraying rounds of 2012 carbamate insecticide, which lasts 
for 4-6 months, is being used. These rounds are being done in selected areas, 
"hotspots", based on epidemiology and potential for transmission.  
 
Other vector control interventions, although not scaled-up nationally, have also been 
used in the past years. Since Stone Town was not covered by IRS, area spraying with 
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pyretheroids was done irregularly to reduce mosquito burden when needed. 
Additionally, larvaciding was done on several ocasions in urban areas whenever 
chemicals were available and where there was a high increase in mosquitoe density. 
ZMCP now plans to regulate the larvaciding activities in the Urban district where IRS 
is not implemented. (personal communication with Juma Hassan Mcha, Head of Vector 
Control Unit – ZMCP, 2012). Environmental management has been advocated by 
ZMCP as a method of malaria control, but these efforts rely on the communities, who 
are responsible for carrying out these activities.  
 
Since 2002, all pregnant women are recommended to receive at least two doses of IPTp 
with SP during the 2
nd
 and 3
rd
 terms of pregnancy. From 2004, the IPTp is given as part 
of the routine antenatal care services.   
 
Additionally, ZMCP established a Malaria Early Epidemic Detection System 
(MEEDS) in 2008. The MEEDS relies on mobile-phone weekly reporting of malaria 
indicators from public health facilities. The surveillance data is forwarded to central 
server and can be viewed by ZMCP through a secure website. From January 2012, all 
public and three private health facilities in Zanzibar participate in weekly reporting. 
When a sudden increase in transmission occurs, a team sets out to confirm and 
investigate the outbreak. Activities to halt outbreaks have included focal distribution of 
LLINs and IRS (personal communication with Abdul-Wahid H. Al-mafazy, Head of 
Surveillance Monitoring and Evaluation Unit – ZMCP, 2012). This system is 
financially supported by PMI and technically supported through RTI.  
 
In December 2005, PMI supported ZMCP in launching the "Kataa malaria" (Reject 
malaria) campaign. The campaign provided information, education and communication 
/behavior change communication (IEC/BCC) support for the malaria control 
interventions that were conducted in Zanzibar, including mass media activities, through 
TV and radio, billboard messages, as well as the production of pamphlets, posters, 
teacher's guides, etc. [125]. Since 2010, IEC/BCC activities are implemented under the 
"Maliza malaria" (Eliminate malaria) campaign, which, up to date, is supported by 
PMI. 
 
Due to the intensive abovementioned malaria control efforts, Zanzibar has been 
successful in dramatically reducing malaria transmission and maintaining low 
transmission rates in the past decade [126, 127] (Figure 3).  
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Figure 3: Prevalence (in the general population) and positivity rates (in suspected 
cases who are tested at the public health facilities) of malaria in Zanzibar in the past 
decade. 
Source: Zanzibar Malaria Control Program (ZMCP, 2012)  
 
Inspired by this success, one of the specific objectives in the 2007-2012 Zanzibar 
strategic plan was to assess the potential for sustainable malaria elimination [116]. 
Consequently, a feasibility assessment was done in 2009 and the conclusion of the 
report was that it would be feasible to reach and maintain malaria elimination with 
currently available tools. However, it was acknowledged that it would be extremely 
challenging, both operationally and financially [117]. Yet, since this report was 
published, Zanzibar has been targeting elimination and is one of the 39 "elimination 
countries" [128]. 
 
Rationale 
Zanzibar has been in the forefront of the renewed fight against malaria. In 2002 it was 
one of the first nations to adopt ACTs, and vector-control interventions have been 
implemented and scaled-up rapidly. These efforts have markedly reduced the malaria 
burden in Zanzibar and have moved the country closer to the goal of malaria 
elimination.   
 
AsAq was adopted in 2007 as a first-line drug by 16 SSA countries including Zanzibar. 
In Zanzibar, AsAq was not co-formulated at the time and was not delivered in age or 
weight specific blister-packs, factors that could reduce correct health worker 
prescribing and dispensing practices as well as consumer adherence. Since low 
adherence to drugs have both personal and public health consequences, it was 
considered important to establish adherence levels and identify reasons for non-
adherence (Study I).   
 
 
IRS 
ACTs 
LLINs 
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In 2005-2006 Zanzibar implemented a stand-alone targeted free mass distribution of 
LLINs. This mass delivery strategy was one of the first of its kind in SSA, and 
assessing the process of such a distribution would allow for identification of barriers in 
the health system that can be improved in order to achieve high and equitable coverage 
in future distributions (Study II). 
 
Despite the rapid decline in malaria transmission in Zanzibar, sustaining high effective 
coverage of vector control interventions is crucial for achieving elimination and for 
avoiding malaria resurgence. Therefore, assessing effective coverage and identifying its 
associated factors is a key step in recognizing barriers to effective coverage and 
estimating the prospects for elimination (Studies II & III). Exploring caretaker 
perceptions of vector control interventions and the intention to continue their use when 
malaria burden further declines, was considered important in order to assess the 
prospect for sustained use of these interventions as Zanzibar approaches elimination 
(Studies III & IV).   
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AIM AND OBJECTIVES 
 
Overall aim 
To assess caretaker uptake of malaria control interventions for under-five children in an 
area where malaria transmission has rapidly decreased. 
 
Specific objectives 
1. To assess caretaker adherence to ACTs freely dispensed at public health 
facilities.  
 
2. To evaluate the system effectiveness of a free mass distribution of long-lasting 
insecticidal nets (LLINs). 
 
3. To assess the effective coverage of vector control interventions. 
 
4. To explore caretaker perceptions of malaria and vector control interventions. 
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METHODS 
Overall study design 
The overall aim and specific objectives were achieved by conducting three quantitative 
surveys and one qualitative study (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Overall study design 
 
 
The studies were conducted over a course of three years, assessing the uptake of 
different malaria control interventions that were being routinely implemented by 
ZMCP. Figure 5 illustrates the timing of each study in relation to the different program 
implementations.  
 
Study I, which assessed caretaker adherence to AsAq regimens, was carried out in Nov 
2006 till Jan 2007. This was approximately 3 years after Zanzibar had implemented 
AsAq as the first-line treatment for uncomplicated malaria, and about 6 months after 
starting to use the "Falmal" co-blistered packaging.  
 
Study II evaluated the different steps and outcomes of the targeted free mass 
distribution campaign of LLINs. It was done in May 2006 during the peak of the heavy 
rains season, nine and four months after the distribution in Micheweni and North A 
districts, respectively.   
 
Study III, which assessed the effective coverage of vector control and intention to 
continue to use malaria prevention methods, as well as caretakers' perceptions of 
malaria and vector control, was done in June 2009 at the end of the heavy rains season. 
 32 
 
This was around seven months after the second free mass distribution in Micheweni 
district, right after the distribution in North A district, and about six months after a 
round of IRS. 
 
Study IV explored caretaker perceptions of malaria and bed-nets, and was conducted in 
Feb-March 2007. This was approximately one year after the targeted mass distribution 
was carried out, and 2-3 months after the second round of IRS was implemented.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: The timing of the studies (numbered in circles) in relation to the different 
major malaria control interventions (in boxes). 
 
 
Study settings and participants  
Study I was conducted in 8 of the 10 districts of Zanzibar. North A and Wete districts 
were excluded since, at the time of the study, all health facilities in these districts were 
engaged in piloting RDTs. It was likely that the routine prescribing and dispensing 
habits in these health facilities would be affected by the extensive training and 
supervision they had undergone. Studies II & III were done in the predominantly rural 
North A and Micheweni districts, as part of the annual malaria surveys that routinely 
took place in these districts. Study IV was carried out only in the North A district (see 
Figure 6). 
 
All participants of the studies were caretakers of under-five children, most of them 
mothers. In Study I, the caretaker who was responsible for administering the medicine 
to the child was interviewed. In Studies II & III an available caretaker was interviewed, 
and priority was given to mothers. In Study IV, female and male caretakers whose 
under-five children had received an LLIN during the targeted distribution were 
purposefully chosen. 
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Figure 6: Zanzibar districts, and locations of the different studies (I-IV) 
 
 
Study design, sampling and data collection 
Study I 
Adherence to the "Falmal" child package was assessed using a cross-sectional follow-
up survey, where caretakers of under-five children who had received AsAq treatment 
for uncomplicated malaria at public health facilities were followed up in their homes 
four days after receiving the three-day treatment. A two-stage cluster sampling [129] 
was used to select the caretakers from 21 health facilities. The health facilities included 
15 PHCUs that were randomly selected from the complete list of PHCUs in the 
districts. All three PHCCs, two district hospitals and the referral hospital were 
purposefully selected. Caretakers were randomly selected from a register of all children 
who had received AsAq treatment for uncomplicated malaria.  
 
The caretaker who was responsible for administering the medicine to the child was 
interviewed in their homes using a structured questionnaire. Closed and open ended 
questions were asked on characteristics of the child and caretaker, instructions and 
drugs received at the health facility, laboratory tests made, amount of drugs dispensed, 
administration of drugs, vomiting of drugs, types and reasons for non-adherence, and 
opinions about the drugs.  
 
Prescription at the health facility was determined by reviewing the patient book while 
drug dispensing was determined by caretaker reporting in combination with 
Unguja  
Pemba 
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examination of the remaining pill package, when available. Caretakers' adherence was 
assessed by the caretaker’s self report in combination with pill count. 
 
Studies II & III  
Uptake of vector control interventions was assessed in two cross-sectional community-
based surveys, where caretakers of under-five children from North A and Micheweni 
districts were interviewed in their homes. Two stage cluster sampling was used [129], 
whereby caretakers were randomly chosen from pre-selected Shehias. The caretaker 
was interviewed using a structured questionnaire with closed and open ended questions. 
In Study II, the caretakers were asked about bed-net ownership and use, experiences 
with the LLIN distribution, perceptions on LLINs and other bed-nets, as well as 
household characteristics. The interviewers also asked to see the nets reported and to 
document whether the nets were hanging above a sleeping space. In Study III, the 
caretakers were asked about their perceptions and beliefs on the malaria situation in 
Zanzibar and vector control interventions provided, household characteristics, use of 
bed-nets and IRS, and their intention to continue using vector control interventions as 
the malaria burden further declines. 
 
Sample size calculations (Studies I, II & III) 
The desired sample size was calculated in relation to the main study outcome. Thus, 
sample sizes were estimated according to caretaker adherence (Study I), and children 
under-five sleeping under an LLIN (Studies II & III). In all studies, calculations were 
done with the assumption that the proportion of the outcome was 50%, as this would 
result in the most conservative sample size. The calculations also accounted for a 
cluster effect of 2, an absolute precision of ±10% and 95% CI. These calculations 
resulted in a desired sample size of minimum 192 participants in the three studies.   
 
Study IV 
In-depth interviews with female and male caretakers were conducted to explore 
perceptions of malaria and bed-nets. The informants were all North A residents who 
were caretakers of children and had received at least one LLIN during the targeted 
distribution. They were purposefully selected by their ability to provide extensive 
answers in the open-ended questions of Study II. The interviews were carried out using 
interpreters and following an interview guide, which was based on the HBM 
framework. They were asked about perceived susceptibility and severity of malaria, 
benefits and barriers to bed-net use, self-efficacy in using bed-nets and cues to action.  
 
Following each interview, the translated transcripts were reviewed to assess whether  
more interviews needed to be scheduled or  whether saturation was achieved, as 
suggested by Dahlgren et al., 2007 [25]. After 19 interviews, it was felt that saturation 
had been reached.   
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Data management 
Data from the quantitative studies (Studies I, II & III) were single entered in CSPro. 
The data was transferred to Excel where it was cleaned and checked for errors and 
inconsistencies. Open-ended questions were reviewed and coded. The data was then 
imported to STATA software, where recoding and generation of new variables 
continued. For example, some continuous variables, such as age and years of education, 
were re-coded into categorical variables.  
 
The recorded in-depth interviews (Study IV) were transcribed verbatim and translated 
from Kiswahili to English by the study interpreters.  
 
Data analysis 
Univariate, bivariate and multivariate analysis (Studies I, II & III) 
Data analysis was done using STATA software. Univariate analysis included 
presentation of frequencies and proportions of different categorical variables, and 
means and medians of continuous variables. Bivariate analysis was performed by using 
chi-square or bivariate logistic regression for dichotomous outcomes. Multivariate 
analysis (MVA) was done on all variables that were at the significance level of p ≤ 0.25 
in the bivariate analysis. Variables considered for MVA were checked for colinearity 
before being entered to the multivariate model. Variables that remained significant in 
the MVA were checked for interactions. P-values and confidence intervals in bivariate 
and MVA were adjusted for cluster effects using STATA svy command. The cluster 
effect was adjusted on the health facility level (Study I), household and shehia levels 
(Study II), and the shehia level (Study III).  
 
Adherence definitions (Study I) 
1. Caretaker adherence was defined as caretaker reporting giving the correct daily 
dosage of one of the two recommended AsAq regimens for the first 3 days from 
receiving the treatment, with the pill count not contradicting this report. 
2. Perfect caretaker adherence was defined as, in addition to the above mentioned 
adherence criteria, the child not having vomited the drugs within half an hour, 
or caretaker having re-administered a vomited dose. 
 
System effectiveness analysis (Study II) 
Success in the four steps of the distribution process were assessed for all eligible 
children who were above one year old, to avoid including children who were not yet 
born at the time of registration. The four steps were:  
 
1. Being registered to receive an LLIN.  
2. Arriving at the distribution point. 
3. Receiving an LLIN. 
4. Sleeping under an LLIN.  
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Three measurements were used to assess each step, as proposed by Krause et al. [130]: 
 
1. Unconditional proportion (UP) – The proportion of children who successfully 
completed a certain step out of all eligible children.  
2. Conditional proportion (CP) – The proportion of children who successfully 
completed a certain step out of those who succeeded in previous steps. 
3.  Accumulated proportion (AP) – The proportion of children who successfully 
completed all steps up to and including a certain step out of all eligible children. 
The overall systems effectiveness was calculated as the AP of all distribution 
steps.   
 
Equity analysis (Studies II & III) 
An asset index was created by principal component analysis (PCA) as suggested by 
Filmer and Pritchett [131]. In Study II, assets which were used in the final model were 
type of floor, walls and roof, sources of water, and owning a mat, cupboard, sofa, clock, 
iron, phone, radio, motorcycle, car, TV and fridge. In Study III, the index was based on 
all socio economic variables and included type of floor, walls and roof, source of water 
and light, type of toilet and cooking facilities, and owning 20 different assets. The 
households were then divided into socio-economic quintiles based on their asset index.  
 
In Study II, the difference in proportions of success of each distribution step between 
the poorest and least poor quintiles was checked for significance using chi-square. The 
equity effectiveness was calculated as the ratio of system effectiveness in the least poor 
and poorest quintiles.  
 
In Study III, effective coverage of IRS and LLINs in different socio-economic quintiles 
was compared and the difference between the poorest and least poor quintiles was 
checked for significance using bivariate logistic regression.  
 
Deductive content analysis (Study IV) 
The HBM served as the main framework of Study IV and its elements (i.e. perceived 
susceptibility, perceived severity, perceived benefits, perceived barriers to bed-net use, 
cues to action and self efficacy) served as categories. Therefore, a deductive (directed) 
approach was applied whereby the categories were pre-determined according to the 
theory used [132, 133]. Meaning units were copied into a matrix where they were 
condensed and assigned a code [134], which was then placed under an HBM category.  
 
Ethical considerations 
All studies have been ethically approved by the appropriate authorities in Zanzibar. 
Studies I, II & IV were approved by the Zanzibar Medical Research Task Force and 
Study III was approved by the Zanzibar Medical Research Ethical Committee 
(ZAMEC).  
 
District and local leaders (Shehas) were informed about all studies, and in Study I the 
health facility staff was also informed. Written consent was obtained from all 
participants before starting the interviews. 
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RESULTS 
Adherence to ACTs (Study I) 
Caretaker adherence to AsAq was 77% (134/174) (95% CI: 67%–87%). Non-
adherence resulted in under-dosing in 30 of the 40 non-adherers, and was most often a 
combination of mistakes such as giving the wrong daily doses (48%; 19/40) or not 
completing the 3-day treatment (30%; 12/40), as well as initiating treatment late or 
skipping pills. The main reasons for non-adherence were misunderstanding or 
forgetting the correct dose regimens (53%; 21/40). Other reasons included forgetting to 
give some of the pills, stopping treatment due to improvement in the child's health, 
difficulty in administering the medicine and thinking the treatment was too strong for 
the child.  
 
The infant dose regimen was in most cases (59%; 39/66) dispensed with an inexact 
number of pills to complete the treatment regimen by cutting off the last 2 pills, and 
providing 2 As and 2 Aq pills, when in fact only 1.5 pills of As and Aq are required 
(Figure 7). This resulted in half pills being left over beyond three days, and although 
not considered as non-adherence, 9 caretakers continued and 20 intended to continue 
the treatment.  
 
Predictors of adherence were caretaker's education exceeding 7 years (OR = 5.08, 
p=0.008) and receiving the exact number of pills to complete the treatment regimen 
(OR = 4.09, p=0.006). Additionally, all caretakers of children who were administered 
the first dose at the health facility had adhered to the treatment.  
 
The majority of caretakers had positive opinions about the drugs. Negative opinions 
included complaints that the drugs were too strong and that they weaken or drowse the 
child, cause loss of appetite and are too bitter. Having positive or negative opinions 
about AsAq was not found to be associated with adherence.  
 
In total, 19% (38/195) of the children vomited at least one dose within half an hour of 
drug intake. Perfect caretaker's adherence was therefore reduced to 63% (110/174) 
(95% CI: 54%–73%) after 24 caretakers, who were otherwise adherent, did not re-
administer a vomited dose. 
 
  
                                   
 
 
 
 
     Figure 7: Treatment instructions for 50/100 mg Falmal 
                     Package 
 
 Day 1 Day 2 Day 3 
'Infant' dose regimen 
(<12 months or  
 <10Kg) 
 
 
 
 
 
 
 
'Child' dose regimen 
(1-6 years or  
 10-20 Kg) 
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Although the objective of the study was to assess caretaker's adherence, health worker's 
poor adherence to the national guidelines was found, as 11% (21/195) of the caretakers 
were excluded from adherence analysis due to receiving inappropriate prescribing 
and/or dispensing of drugs. Additionally, there was a large variance in adherence 
according to the health facility that dispensed the drug (29% to 100%). Caretakers who 
received the AsAq from PHCUs were significantly more likely to adhere (82%; 
108/131), compared to those who received the medicine from hospitals and PHCCs 
(60%; 26/43) (p=0.03) (data from Study I). 
 
System effectiveness of a targeted free mass distribution 
of LLINs (Study II) 
The system effectiveness (AP) of the free mass distribution, in children 1 to 5 year old, 
was higher in the North A (87%) than in the Micheweni (49%) district. This was a 
result of higher conditional proportions of success in every one of the distribution steps. 
Effective coverage of the distribution (UP of the final step), was higher than the system 
effectiveness, at 88% in North A and 58% in Micheweni (Figure 8). 
 
 
       North A        Micheweni 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Unconditional Proportion (UP), Conditional Proportion (CP) and 
Accumulated Proportion (AP) of the LLIN distribution process in North A and 
Micheweni districts.  
 
When comparing the proportions of success in each distribution step between the 
poorest and the least poor quintiles, equity was maintained in all distribution steps in 
North A district, resulting in an equity ratio of 1. In Micheweni district, system 
effectiveness was 1.5 times higher in the least poor compared to the poorest, with the 
greatest inequity occurring in the registration step (Table 3).  
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Table 3: Conditional Proportion (CP), Unconditional Proportion (UP) and 
Accumulated Proportion (AP) of the distribution steps in the poorest and least poor 
quintiles. 
 
 
 
 
Effective coverage of vector control interventions 
(Studies II & III) 
The overall effective coverage of LLINs in all under-five children in Study II was also 
assessed, as was the effective coverage by other types of bed-nets. In Study III, the 
effective coverage of under-five children to both LLINs and other types of nets, as well 
as IRS, was evaluated (Table 4). Effective coverage of LLINs and IRS in under-five 
children was equitable between the poorest and least poor quintiles. 
 
Data on household coverage is also available, and in 2006 96% (375/392) of the under-
five children in Micheweni district were living in a house with at least one bed-net, and 
86% (336/392) were living in a house with at least one LLIN. In North A district, 99% 
(393/395) of the under-five children were living in a house with at least one bed-net, 
and 97% (383/395) were living in a house with at least one LLIN (data from Study II). 
In 2009, 99% (683/693) under-five children were living in a house with at least one 
bed-net, and 96% (663/693) were living in a house with at least one LLIN. However, 
only 64% (446/693) of the under-fives were living in a house where there was at least 
one bed-net per two persons, and 45% (311/692) were sleeping in a household where 
there was at least one LLIN per two persons (data from Study III).  
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Table 4: Effective coverage of vector control interventions in children under-five in 
North A and Micheweni districts in 2006 and 2009. 
 
 
 
In 2009, effective coverage of the total population was lower than that of under-fives at 
66% for ITNs (2,094/3,170) and 60% for LLINs (1,905/3,170), while IRS coverage 
remained high at 95% (3,266/3,455). While 57% of the population (1,776/3,095) was 
covered by both interventions, effective coverage by at least one vector control 
intervention was high at 97% (3,004/3095) (data from Study III). 
 
In 2006, factors that were found associated with LLIN effective coverage of under-five 
children, in both districts, were a child receiving an LLIN and caretakers thinking that 
LLINs were better than conventional nets.  
 
 2006 2009 
 North A Micheweni Total North A Micheweni Total 
LLINs 
87% 
(338/389) 
57% 
(216/380) 
72% 
(554/769) 
71% 
(241/338) 
68% 
(218/322) 
70% 
(459/660) 
Conventional 
treated nets 
5% 
(19/389) 
27% 
(102/380) 
16% 
(121/769) 
8% 
(26/338) 
6% 
(18/322) 
7% 
(44/660) 
Conventional 
untreated nets 
5% 
(18/389) 
4% 
(15/380) 
4% 
(33/769) 
9% 
(31/338) 
8% 
(25/322) 
9% 
(60/660) 
Total treated nets 
(ITNs) 
92% 
(357/389) 
84% 
(318/380) 
88% 
(675/769) 
79% 
(267/338) 
73% 
(236/322) 
76% 
(503/660) 
Total bed-nets 
96% 
(375/389) 
88% 
(333/380) 
92% 
(708/769) 
89% 
(301/338) 
81% 
(262/322) 
85% 
(563/660) 
IRS    
95% 
(324/342) 
94% 
(314/333) 
95% 
(638/675) 
Both 
interventions 
(LLINs and IRS) 
   
68% 
(225/329) 
64% 
(201/314) 
66% 
(426/643) 
At least one of 
the interventions 
(LLINs and IRS) 
   
98% 
(321/329) 
98% 
(307/314) 
98% 
(628/643) 
Both 
interventions 
(ITNs and IRS) 
   
75% 
(248/329) 
70% 
(219/314) 
73% 
(467/643) 
At least one of 
the interventions 
(ITNs and IRS) 
   
98% 
(324/329) 
98% 
(307/314) 
98% 
(631/643) 
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Bed-net usage patterns (Studies I, II & III) 
Seasonality (Studies III & IV) 
Interrupted bed-net usage in adults was common, whereby 33% of caretakers 
(171/514) reported to be using the bed-nets seasonally (data from Study III), while in 
under-five children seasonal usage was less common and was reported by 25% of the 
caretakers (125/508) (Study III). In Study IV, seasonality was seen to have an effect 
on different HBM elements and varied due to temperatures and rainfall. The heat 
caused by sleeping under the bed-net was considered as a barrier in the hot season, 
while in the cool season it was considered as a benefit. In the rainy season mosquito 
density was perceived to be higher, which affected both perceived malaria burden and 
mosquito nuisance. The mosquito nuisance affected the perceived added benefit of 
the bed-nets as protection against mosquito bites. The change in malaria burden might 
have an effect on the perceived susceptibility to malaria and the perceived benefit of 
using the net as protection against malaria, although these associations were not 
explicitly mentioned (Figure 9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: The effect of seasonality on elements of the Health Belief Model 
 
 
Prioritizing children and bed-net sharing (Studies II, III & IV) 
Under-five children were prioritized when it came to bed-net usage (Studies III & IV). 
This is evident from the higher reported continuous usage in children, mentioned 
above, as well as from the significantly higher overall proportion of children under-five 
sleeping under bed-nets as compared to over-fives. LLIN usage was especially higher 
in under-five children (70%; 459/660) than in over-fives (58%; 1,446/2,510) (Figure 
10) (data from Study III).  
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In Study II it was found that of the 1,307 nets that were in use (excluding 127 that were 
not being used), 54% (701/1,307) were used by a single person while 40% (519/1,307) 
were shared by two people, 6% (83/1,307) were shared by three people, and four nets 
were shared by 4 people. While 45% (292/642) of the under-fives used a net by 
themselves, the others shared a net with one older household member (36%; 229/642), 
two older household members (9%; 56/642) or other under-fives (6%; 41/642) (data 
from Study II).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Under-five children and Over-fives sleeping under different types of bed-
nets (data from Study III)  
 
 
Caretaker perceptions on malaria and vector control  
(Studies II, III & IV) 
Risk perceptions 
Awareness of malaria among the caretakers was high but risk perceptions were low as 
the illness was seen as easily curable and uncommon (Study IV). The majority of 
caretakers (65%; 363/560) did not currently see malaria as a serious health problem 
(Study III). However, perceived susceptibility was strongly linked to mosquito density 
(Study IV) and was also considered higher in children (Study III & IV). A majority of 
caretakers believed that children were most at risk of contracting malaria (83%; 
467/560), and most at risk of developing malaria complications (80%; 450/560) (Study 
III). One father explained: 
 
"I pity the child because an adult can at least hit it [the mosquito] and it 
will leave, but a child is not able to do that….A child's health is delicate 
so he can get infected quickly" 27 year old father (Study IV). 
 
No association was found between different risk perceptions and LLIN effective 
coverage in under-five children (Study III). 
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Benefits and barriers 
Caretakers spontaneously attributed the malaria reduction in Zanzibar mainly to bed-
nets (41%; 231/560) and IRS (37%; 206/560). Malaria prevention methods mentioned 
by caretakers were bed-nets (75%; 414/560), environmental cleanliness (30%; 
167/560) and IRS (18%; 100/560) (Study III).  
 
Bed-nets were highly appreciated by caretakers and the majority of caretakers agreed to 
the statement that bed-nets were useful in preventing malaria and mosquito bites (Study 
III). The added benefit of bed-nets as protection against mosquito nuisance was also 
highlighted and seasonal and overall increase in mosquito burden was the main cue to 
action of using a bed-net (Figure 9).  
  
"I think it is good [to use a bed-net] because the mosquitoes cannot penetrate. 
During the night I just enter into it and sleep well. If you do not cover yourself 
with a bed-net, you will not be able to sleep. You will have to chase the 
mosquitoes away here and there, they bite you sometimes, but if you sleep with 
it you will get a very nice sleep without problems." 44 year old mother (Study 
IV) 
 
Study IV also points to high self-efficacy of female caretakers, who are mainly 
responsible for covering the children with bed-nets.  
 
Although some characteristics of LLINs were more appreciated (i.e. its color, strength, 
and ability to keep mosquitoes away), while others were considered problematic (i.e. 
large mesh size and insufficient height), satisfaction with these specific characteristics 
were not significantly associated with under-five use of LLINs (Study II). 
 
The only major barrier to bed-net use was heat, as explained in more detail above under 
seasonality. Additionally, a barrier to bed-net ownership was the increasingly high cost 
of bed-nets (Study IV).  
 
IRS was also perceived to be useful in preventing malaria and mosquito bites, though to 
a lesser extent than what was reported for bed-nets. Advantages of IRS that were 
spontaneously mentioned by caretakers included mosquito reduction (48%; 269/560) 
and insect reduction (41%; 230/560), while malaria reduction was mentioned by only 
19% (104/560) of the caretakers (Study III). IRS shortcomings included the perceptions 
that their effect is temporary and specific only to malaria-carrying Anopheles 
mosquitoes (Study IV). Other disadvantages of IRS were mentioned by 20% (112/550) 
of the caretakers, and included side-effects such as itching and increased mosquito and 
insect populations (especially of bed-bugs) (Study III).   
 
Study III indicates that most caretakers (85%, 456/536) found it useful to combine 
several preventive measures together, and over twenty percent of the caretakers 
(114/555) reported using additional means of malaria prevention, such as 
environmental cleanliness, canned insecticide, coils and other devices. 
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Sustainability 
The importance of sustaining bed-net usage after malaria had declined was stated by 
93% (502/537) of the caretakers, mainly because of the continued mosquito 
prevention and also because of continued malaria protection. For the same reasons 
sustained IRS after malaria reduction was acknowledged by 87% (487/546) of the 
caretakers. The majority of caretakers (95%; 500/524) mentioned that they would 
continue using preventive measures for their under-five children (Study III).  
 
However, there was also an indication of strong dependency on the government and 
health workers to provide vector control interventions (Study IV). This is in line with 
the finding that in 2006 the proportion of nets that were reported to have been received 
for free was 63% (890/1,404), with 55% (791/1,435) being freely distributed LLINs 
(data from Study II). In 2009, the proportion of freely distributed nets increased and of 
those who slept under bed-nets, less than 20% (458/2,332) slept under a bed-net that 
was bought, while 77% (1,795/2,332) were sleeping under a freely distributed LLIN 
(data from Study III).  
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DISCUSSION 
Discussion of main findings 
In this thesis, the uptake of three malaria control interventions was assessed: 
Artemisinin-based combination therapies (ACTs), bed-nets and indoor-residual 
spraying (IRS). These three interventions are essential in reducing the malaria 
transmission (basic reproduction rate). Once the basic reproduction rate is below one, 
malaria elimination can be achieved. While the vector control interventions (i.e. bed-
nets and IRS) reduce the efficiency of the mosquito vector (vectorial capacity), the 
infective parasite pool in humans or duration of infectivity is reduced by prompt and 
appropriate case management [1].   
 
Vector control 
Vector control interventions have an important role to play in reducing malaria 
transmission during malaria control, interrupting malaria transmission to achieve 
malaria elimination and preventing the re-establishment of malaria transmission after 
elimination had been achieved. 
 
Effective coverage 
Findings from Zanzibar demonstrate high and equitable effective coverage of vector 
control interventions following free mass distributions of long-lasting insecticidal nets 
(LLINs) and IRS campaigns (Studies II & III). One of the indicators that is commonly 
used to assess different insecticide-treated nets (ITN) delivery mechanisms is ITN use, 
especially by the vulnerable groups (i.e. pregnant women and under-five children). In 
this thesis the term ITN effective coverage is used in the same way as ITN use; both 
terms encompass access and adherence to ITNs.  
 
Bed-net delivery mechanisms 
With the aim of improving access to ITNs, a wide range of delivery mechanisms have 
been implemented since the late 90s. These included public sector, private sector, 
mixed public-private and community-based deliveries, that provided free, partially 
subsidized or unsubsidized ITNs to the public [135].  
 
While private sector approaches did not normally result in high or equitable effective 
coverage [136, 137], mixed public-private sector delivery generally yielded better 
outcomes. The KINET project in Tanzania involved a social marketing program as well 
as a voucher scheme targeting pregnant women and mothers of small children. This 
project resulted in an increase in ITN effective coverage of children under-five and 
pregnant women. However, although equity had increased, socio-economic inequities 
were still present [71, 138, 139]. The national voucher scheme in Tanzania also 
demonstrated a steady increase in ITN effective coverage in pregnant women and 
under-five children, though it did not achieve equity [140, 141].  
 
Since 2003, it was increasingly recognized that ITNs should be distributed free of 
charge in order to rapidly achieve high and equitable coverage [48]. Targeted 
distribution of free ITNs and LLINs to under-five children in conjunction with 
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immunization campaigns were shown to achieve these goals, with effective coverage in 
under-five children ranging from 46% in Senegal and Zambia to 81% in Madagascar, 
with improved equity [142-147]. Stand-alone targeted mass distribution campaigns of 
LLINs for under-five children, which were not in conjunction with other health 
activities, such as the one conducted in Zanzibar in 2005-2006, have also been 
implemented in Kenya and Tanzania [148, 149]. In Tanzania, the mass distribution 
resulted in under-five usage of LLINs at 64% [149]. In Zanzibar, following the targeted 
mass distribution, effective coverage of the distributed LLINs was high and equitable in 
the North A district, which is representative of the distribution scale-up, at 87%. ITN 
effective coverage in North A district was higher at 92% (Study II). These findings 
demonstrate that free targeted mass distribution of bed-nets, either through stand-alone 
campaigns or integrated with other health interventions, are an effective delivery 
strategy to increase equitable effective coverage in the targeted population.  
 
Although targeting and prioritizing the under-five children and pregnant women has 
been a useful way of providing personal protection to these vulnerable groups, it has 
become increasingly recognized that high coverage levels of the entire population 
would utilize a community protective effect. This protective effect would increase the 
benefit to the entire population, including the vulnerable groups [150]. This is 
especially relevant since children above the age of five and adults comprise a large 
portion of the population, and are more attractive to mosquitoes, and thus they 
represent a large reservoir of parasites [95, 151, 152]. Additionally, as malaria 
transmission is reduced the entire population becomes vulnerable to malaria as they 
lose their acquired immunity. For countries targeting elimination, universal coverage 
is important due to the vital role that vector control plays in interrupting malaria 
transmission [46]. Due to the above-mentioned reasons, Roll-Back Malaria (RBM) 
shifted its target in 2008 from covering vulnerable groups to achieving universal 
coverage of one LLIN for every two people [48]. Accordingly, the mass distribution 
technique had changed and mass distributions were no longer targeting only the 
vulnerable groups. In Sierra Leone, an un-targeted distribution resulted in under-five 
effective ITN coverage of 73%, and in Nigeria under-five use was at 62% of those 
living in households that own at least one ITN [98, 153]. In Zanzibar, after two LLINs 
were distributed per household, overall under-five ITN effective coverage was at 76%, 
and LLIN effective coverage was at 70% and equitable (Study III). These findings 
show that effective coverage of under-five children with LLINs remained relatively 
high, even after the change in the distribution strategy from a targeted mass distribution 
to an un-targeted one. 
 
Perhaps more relevant in assessing advances towards the elimination goal in Zanzibar 
is the overall effective coverage in the entire population. In 2009, the ITN effective 
coverage of the entire population was 66% and LLIN effective coverage was 60% 
(Study III). According to the elimination feasibility assessment, 60% is the minimal 
vector control coverage required for reaching the basic reproduction rate of less than 
one and, consequently, achieving elimination. It is predicted that achieving elimination 
with 65% effective coverage would take approximately two decades  [117].  
 
While free mass distributions have led to equitable and rapidly increased coverage 
[148], and are probably the most efficient "catch-up" strategy available, sustaining high 
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coverage would benefit from complementary routine interventions ("keep-up"). 
Therefore, different delivery strategies should be used to complement each other [154-
157]. In Zanzibar, however, periodical mass distributions in 3-year intervals have been 
carried out (2006, 2009, 2012). This strategy might create gaps in the effective 
coverage due to population growth and in-migrations. Perhaps the establishment of 
"keep-up" strategies, including reinforcement of continuous LLIN delivery through the 
antenatal care services, as well as finding additional routine delivery strategies, such as 
provision of LLINs during immunizations or through schools, would elevate the 
effective coverage and make elimination more feasible.  
 
Integrated vector control  
In 2009, the 95% effective coverage with IRS was found to be much higher than that of 
LLINs and bed-nets in general (Study III). This is probably due to that fact that 
spraying one house effectively covers all of its inhabitants, while effective coverage of 
LLINs is still regarded as an individual intervention. Additionally, IRS does not require 
continuous adherence by community members beyond their initial agreement to have 
the house sprayed.  
 
Together, IRS and ITNs effectively covered 98% of under-five children, and 97% of 
the total population (Study III). Although the use of ITNs and IRS simultaneously have 
the potential of producing an additive effect, it is more likely to achieve such an effect 
when different types of insecticides are used for IRS and ITNs. It was specifically 
recommended that when pyrethroid treated bed-nets are used, the IRS insecticide 
should have a different mode of action [37]. The fact that in 2009 pyrethroids were 
used as insecticides for both LLINs and IRS in Zanzibar does not optimize the potential 
of combining these two vector control interventions. Nevertheless, even when additive 
effects are not considered, the effective coverage to a vector control intervention was 
elevated. With such high effective coverage of vector control, the prospects of 
achieving elimination rise, and it has been predicted that with 100% effective coverage, 
elimination could be achieved in less than 5 years [117].  
 
Access 
Access to bed-nets can be assessed by measuring household ownership. In Tanzania, 
household ownership of at least one bed-net had increased from 37% to 73% during 
three years of an intense social marketing efforts in the KINET project [138]. Three 
years of the national voucher program in Tanzania resulted in a bed-net ownership 
increase from 44% to 65% [140]. Targeted free mass distributions to under-five 
children have resulted in ITN household ownership ranging from 94% in households 
with under-fives [144] to 63% in all households [145]. In Zanzibar, after the targeted 
mass distribution of LLINs, 96% of the children in Micheweni and 99% of the children 
in North A were living in a house that owned at least one bed-net, and 86% and 97% of 
children were living in a house with at least one LLIN, respectively (Study II). The un-
targeted mass distribution in Zanzibar has resulted in 99% of the under-five children 
living in a house with at least one bed-net, and 96% living in a house with at least one 
LLIN (Study III). Other un-targeted distributions have also resulted in high access to 
bed-nets, where household ownership of at least one bed-net in Sierra Leone reached 
88% [153] and 70% in Nigeria [98].  
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However, ownership of one bed-net per household does not indicate how much access 
an individual within that household has to a bed-net. Intra-household access can be 
better determined by measures that are in line with the universal access definition of 
'one bed-net per two people'. According to this definition, in Zanzibar, although 99% 
and 96% of under-fives were living in a house with at least one bed-net and LLIN, 
respectively, only 64% and 45% were living in a house that reached universal coverage 
of bed-nets and LLINs (Study III). Similarly, in Sierra Leone, the 88% household 
coverage was reduced to 36% households with universal coverage [153]. High intra-
household access was previously found to be the strongest determinant of use [98], and 
specifically for under-five use [158].  
 
A more specific assessment of LLIN access can be achieved by reviewing the three first 
steps of the targeted mass distribution in the system effectiveness analysis. Due to the 
fact that the different steps are not mutually exclusive, those who were not registered 
could have still arrived at the distribution point and have ended up receiving an LLIN, 
and even those who did not arrive at the distribution point could have still received a 
net from a health worker at a different occasion. Therefore, the unconditional 
proportion (UP) of the third step is most appropriate to describe the overall access of an 
eligible child to an LLIN. In Micheweni district 70%, and in North A district 96% of 
the eligible children received an LLIN. In North A access to an LLIN was also 
equitable between the poorest and least poor. The higher access in North A district, as 
compared to Micheweni district, was especially attributed to incomplete registration of 
children and insufficient amount of LLINs for distribution during the pilot distribution 
in Micheweni. However, even children who did not personally receive an LLIN during 
the distribution could still have accessed and slept under an LLIN, most likely by using 
one that was distributed to another family member or sharing a net with family 
members who had received an LLIN in the same distribution (under-five siblings or 
pregnant mothers) (Study II).  
 
Assessments of success in different steps of a delivery system were also done in order 
to evaluate a voucher scheme in Tanzania [141] and Ghana [159]. However, the 
voucher scheme in Tanzania, mostly due to the fact that the women had to treat their 
own nets with packaged insecticide, resulted in a low (30%) and inequitable cumulative 
rate of success [141]. In Ghana, the voucher scheme resulted in even lower success 
rates, mainly due to women not being offered a voucher and women not using the 
voucher to purchase a net. This type of detailed assessment, similar to the system 
effectiveness analysis in Study II, is important in order to find the specific barriers in 
the health system that can be improved [108]. 
 
In Zanzibar, access to LLINs highly depends on the government delivery strategies, 
since they are normally not available in the local market and private shops. In 2006, all 
LLINs identified in the survey were deployed through the targeted mass distribution, 
and in 2009 the vast majority of LLINs in Zanzibar were freely distributed nets (less 
than 6% were either bought or delivered through the short-lived voucher system).  
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Adherence 
Adherence to LLINs was assessed in the system effectiveness analysis in Study II, as 
the conditional proportion of the final step of having a child sleep under an LLIN. This 
figure represents the caretaker's adherence to the LLIN intervention, as it signifies the 
proportion of children sleeping under an LLIN out of all the children who have 
received an LLIN. Adherence was at 74% in Micheweni district and at 91% in North A 
district (Study II). The higher adherence in North A district as compared to the pilot 
distribution in Micheweni district could be due to, among other factors, the emphasis 
on information, education and communication / behavior change communication 
(IEC/BCC) strategies in the distribution scale-up. However, although adherence was 
improved in the distribution scale-up, it still remained the weakest step compared to the 
preceding steps that determine access. The problematic gap between bed-net ownership 
and bed-net use has also been highlighted in several other studies [160, 161].  
 
Seasonality 
One factor that has been hampering continuous bed-net adherence is seasonality. The 
seasonal fluctuations interrupted regular use of bed-nets due to changes in perceived 
mosquito density, and possibly perceived malaria burden, as well as the discomfort of 
sleeping under a bed-net during the hot seasons (Study IV), as has previously been 
suggested by Winch et al. [93]. Seasonal usage was evident already from the early 
randomized control trials where bed-net adherence was found to increase in the wet 
and cold seasons as compared with the dry and hot seasons in Kenya and Ghana [94, 
162, 163]. This trend continued throughout the years, and an increase in bed-net use 
was often observed during the cool, rainy seasons [100, 145, 146, 161, 164]. In 
Zanzibar, 33% of the caretakers and 25% of the under-five children were reported to 
be using bed-nets seasonally (Study III). Since heat was found to be the only major 
barrier to bed-net use (Study IV), delivery of LLINs with larger mesh size to allow 
for ventilation, could possibly improve bed-net use in the hot season. 
 
Intra-household adherence 
In Zanzibar, there was a strong indication of prioritizing children when it came to bed-
net usage (Studies III & IV), and in 2009, even after an un-targeted distribution, 
children under-five were still more likely to use bed-nets (Study III). Age has 
previously been shown to be a determinant for adherence to bed-nets. Early experiences 
during a randomized control trial in Kenya indicated that adherence to bed-nets was 
higher in adults who were prioritized in using bed-nets due to their role as income 
providers. Under-fives were also less likely to sleep under a bed-net as it was perceived 
to be too hot or disrupt sleeping arrangements [94, 99]. Adult males were also found to 
be more likely to use bed-nets in a study done in Burkina Faso [96]. However, in a 
review of household surveys conducted from 1991 till 2001, it was shown that 
children's use of bed-nets increases with ownership, and that bed-net use was equal or 
higher in children as compared to adults in most settings, excluding findings from 
Zimbabwe, Kenya, Rwanda and Burkina Faso [164]. As delivery strategies focused 
more on targeting the vulnerable populations through targeted subsidies, free 
distributions and the accompanying IEC/BCC efforts, these groups were increasingly 
prioritized. Targeted delivery strategies to pregnant women resulted in an increase in 
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bed-net use in women and their children [165-167]. Similarly, following the targeting 
of under-five children, studies covering a wide-range of settings in Sub-Saharan Africa 
(SSA) have demonstrated a trend of prioritizing under-five children throughout the past 
decade [95, 97, 160]. Prioritizing children has continued even when distributions are no 
longer specifically targeting under-five children [98, 153].  
 
In Zanzibar, under-five children most commonly shared a bed-net with one older 
household member (Study II). Sleeping arrangements influence who in the household 
uses the bed-net. In addition to targeting pregnant women, mothers' habit of sleeping 
with their young children also resulted in the overall observed advantage of females in 
the reproductive age when it comes to bed-net use [97, 98, 153]. When both parents 
share a sleeping space with their children, they are both protected under a bed-net, and 
this could explain the rise in bed-net use in the 20-44 age group that was shown in 18 
SSA countries [95].  
 
Risk perceptions  
Risk perceptions of malaria in Zanzibar were low, with low perceived susceptibility 
and severity (Studies III & IV). Theoretically, according to the Health Belief Model 
(HBM), perceived susceptibility to a disease would influence an individual's readiness 
to engage in a health prevention action [78]. Reduction in perceived susceptibility has 
previously been shown to lower adherence to preventive measures, as in the case of  
childhood vaccinations, that become less appreciated for their benefits and, instead, 
more attention is given to their side-effects, after incidence of illnesses are reduced 
[168, 169]. While seasonal reduction in bed-net usage due to lower perceived risk of 
mosquitoes and malaria in the dry seasons was previously reported [93], reduction in 
bed-net use due to overall reduction in malaria burden has rarely been explored. One 
exception is a qualitative study done in Vanuatu where bed-net use was maintained in 
areas of low perceived risk of malaria [170]. High community acceptance of IRS has 
also been maintained in Southern Africa despite its success in dramatically reducing 
malaria burden [171]. These findings are in line with findings in Zanzibar, where 
despite the low risk perceptions, effective coverage of vector control interventions 
remained high (Study III). High perceived vulnerability of children is consistent with 
the prioritizing of children when it comes to bed-net use; although this perception was 
not found to be significantly associated with LLIN use (Studies III & IV).  
 
Perceptions of vector control interventions 
Bed-nets and IRS were highly appreciated by caretakers and were recognized as the 
main causes of malaria reduction in Zanzibar. In addition to the benefit of malaria 
reduction, both interventions, and especially bed-nets, were appreciated as protection 
against mosquito nuisance (Studies III & IV). This added benefit of bed-nets was 
previously documented in several countries [99, 100, 172, 173], and was most likely 
the main reason for continued use after malaria burden was reduced in Vanuatu [170]. 
Thus, it can be assumed that as long as there is need for protection against mosquito 
nuisance, bed-nets will remain desirable. However, different perceptions of bed-nets 
were not found to be significantly associated with LLIN use (Study III). 
 
IRS was slightly less valued in comparison to bed-nets (Study III), as was 
documented in Mozambique [174]. While it was as well appreciated for general 
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insect reduction (Study III), it was also blamed for mosquito and insect increase 
(Studies III & IV). Bed-bug increase was previously reported from studies where 
dichloro-diphenyl-trichloro-ethane (DDT) was used for IRS [105]. Other 
disadvantages of IRS, which have also been observed in Mozambique [174], included 
its short lived effect of the insecticide and the belief that it affects only Anopheles 
mosquitoes (Studies III & IV). Reported side effects of IRS, such as itching (Study 
III), were also in line with previous findings [103]. However, despite these 
shortcomings, IRS was still well accepted, and community members had agreed to 
the spraying (Study III). This is in line with findings from Mozambique, where 
acceptance of IRS relied more on socio-political factors than on perceptions [174, 
175].  
 
Simultaneous use of bed-nets and IRS was highly acceptable, and caretakers valued 
the combination of several interventions (Study III). There was also no indication that 
IRS would be considered as a replacement for bed-nets, given its perceived 
disadvantages (Study IV). This is in contrast to previous findings indicating that 
additional protective measures would substitute rather than complement bed-nets [97, 
102].  
 
Sustained adherence 
Studies II, III & IV indicate that sustained adherence to malaria control interventions by 
caretakers, in the face of declining malaria-transmission, is possible. This is supported 
by high effective coverage rates after malaria burden has markedly declined (Studies II 
& III), and by the reported intentions for their continued use after the malaria burden is 
further reduced (Study III). However, as malaria burden further declines and malaria 
becomes a rare disease, the community may experience "elimination fatigue" [48]. 
Community members might not be motivated to continue using or accepting preventive 
measures and may also relax the prompt treatment seeking behaviour associated with 
malaria. Therefore, it is necessary to engage the community in malaria elimination 
efforts and ensure that the community is aware of the continued risk of malaria 
resurgence and re-introduction [48]. It was previously found that involving the 
community in all stages of the IEC/BCC activities, from early planning [176] to the 
implementation stages [177], were vital for their success. Community-directed 
interventions, where the communities themselves direct the planning and 
implementation of intervention delivery, were found to be effective in bed-net 
interventions [177, 178].    
 
Case management 
Case management is important in treating malaria patients and reducing malaria 
morbidity and mortality. In addition to being a curative measure, it also has preventive 
traits as it reduces the duration of infectivity in humans and thus leads to reduction of 
malaria transmission. In the context of malaria elimination it is extremely important to 
identify and properly treat people infected with malaria as soon as possible to avoid 
onward transmission.   
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Adherence 
Caretakers’ adherence to Artesunate-Amodiaquine (AsAq) was shown to be moderate 
at 77% (Study I). However, the outcome could be considered quite good taking into 
account the facts that the drug was not co-formulated or optimally packaged, and that 
the health workers' dispensing practices were not optimal. It was difficult to compare 
the adherence level with other ACT adherence studies due to differences in ACTs used, 
methodologies and adherence definitions. Adherence in other studies varied from 39% 
to 97% for Sulfadoxine-pyrimethamine and artesunate combination [84, 179], 
Artemether-Lumefantrine (AL) combination [82, 83, 85, 86, 180-182], and AsAq 
combination [83, 183, 184]. These drug combinations all differ in dose regimens, 
formulation and packaging. In some studies the health workers were given special 
training before the assessment [83, 184], while others assessed adherence under routine 
conditions following a policy change [182]. Additionally, definitions of adherence vary 
across studies. While in some studies adherence is assessed by looking at the number of 
tablets left over when the treatment was supposed to be completed [184], others 
followed a more strict definition and took into account the reported timing and amount 
of each dose intake [85]. No recommended standard definition or methodology for 
adherence could be identified. The approach in Study I was to study adherence to AsAq 
under routine conditions and taking into consideration intake of correct daily dose 
during the three-day treatment.  
 
In Study I, non-adherence mostly resulted in under-dosing. Sub-optimal drug levels can 
have implications on treatment failure [80], on the development of resistance to the 
antimalarial drug [81], and on infectivity. The major reasons given for non-adherence 
were caretaker misunderstanding or forgetting the correct dose regimens (Study I), as 
was also found previously in other studies [180, 183]. These obstacles could potentially 
be resolved by improving instructions either through better communication with the 
health worker [84, 91, 92, 185] or through providing simple pictorial inserts [185] that 
can be understood even by illiterate caretakers. Simplifying instructions are especially 
important given the finding that low education level was associated with non-
adherence, as was previously shown in Zambia and Uganda [84-86].  
 
One factor associated with non-adherence was the health worker's practice of 
dispensing inaccurate number of pills to complete the dose regimen. This practice also 
allowed for continuation of the regimen beyond the three-day-treatment. In 2010 (after 
Study I was done), a co-formulated AsAq tablet, packaged in four dose-specific packs 
was introduced in Zanzibar. This new co-formulated and blister-packed drug has likely 
improved adherence to AsAq, as there is evidence that age or weight specific blister-
packs enhance both caretaker's [87, 88, 92, 186] and health workers' [187] adherence. 
 
Administering the first dose at the health facility, which was also associated with 
adherence (Study I), is yet another intervention that can be reinforced at the health 
facility level. This practice would also be beneficial in avoiding late initiation of 
treatment and create an opportunity for re-administration of a vomited dose. Although 
this is a general treatment guideline [188], it is a practice that is rarely carried out [84, 
92, 187]. 
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Access 
Although access to ACTs was not assessed in this thesis, achieving high access to 
efficacious malaria treatment is necessary for all malaria infected individuals. Access to 
malaria treatment depends, first of all, on health seeking behavior. The importance of 
seeking timely and appropriate treatment should therefore be highlighted and 
reinforced.  
 
While ACTs are freely distributed at the public health facilities to all patients who are 
diagnosed with uncomplicated malaria, stock-outs and expired drugs sometimes hinder 
their availability. General efforts are being made in Zanzibar to improve the delivery of 
drugs and other supplies to the health facilities by employing the "pull" system. With 
the "pull" system, health facilities are responsible for requesting the supplies, while in 
the "push" system supplies are being delivered on the basis of forecasts that predict the 
quantities that would be needed (Personal communications with Mwinyi Msellem, 
Medical Laboratory Scientist –ZMCP, 2012). However, even when drugs are available, 
health care provider's non-compliance with national guidelines can hamper caretakers' 
access to appropriate treatment regimens. Findings from Study I indicate that in 11% of 
the cases health care providers prescribed and/or dispensed an incorrect dose regimen.  
 
Making ACTs available in the private sector is pursued through the Affordable 
Medicines Facility - malaria (AMFm) program. AMFm, which has been implemented 
in Zanzibar since 2010, aims to ensure affordable drugs in the private sector through 
provision of heavily subsidized ACTs. Free and widespread availability of efficacious 
antimalarials are seen as a priority as Zanzibar approaches elimination. Since it is 
imperative that infected persons clear infection as soon as possible to avoid onward 
transmission, barriers to access and adherence should be removed [117].  
 
Malaria elimination in Zanzibar  
Massive financial and operational support that came with the world's renewed interest 
in malaria reduction has enabled Zanzibar to scale-up their efforts against malaria and 
achieve marked reductions in the malaria burden. After conducting an elimination 
feasibility assessment [117], Zanzibar has made the decision to target malaria 
elimination. Although Zanzibar is not an ideal candidate for elimination, it has several 
advantages that elevate its prospects for elimination: First, malaria transmission has 
been reduced in recent years [128, 189] to a point where it complies with the WHO 
epidemiological criteria for entering the pre-elimination phase [46]. Second, Zanzibar is 
an isolated archipelago [189] and thus has less importation risk by the vector and by 
infected humans [128]. Third, Zanzibar is a small nation with a manageable population 
size [189]. 
 
On the other hand, disadvantages include the fact that Zanzibar has a historical high 
innate transmission risk [117]. Being a low-income nation with generally poor health 
and a weak health system will make it challenging to keep a low burden disease at a 
high priority, although being a low-income country does have the advantage of being 
eligible for financial aid [189]. Also, its proximity to the mainland and the substantial 
daily incoming traffic of visitors, migrants and returning residents maintains the risk of 
importation [117]. 
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The prospects for achieving and maintaining elimination highly depends on the 
vulnerability and receptivity of an area. Vulnerability is elevated with "either proximity 
to malarious areas or resulting from the frequent influx of infected individuals or 
groups and/or infective anophelines" [46]. Once parasites are imported, local 
transmission can be re-established due to high receptivity. Receptivity is "the abundant 
presence of anophline vectors and the existence of other ecological and climatic factors 
favoring malaria transmission" [46]. Zanzibar has high receptivity, evident by its high 
innate risk of transmission, and high vulnerability, due to the risk of importation by 
infected individuals. Thus, the greatest challenge to reaching elimination and then 
maintaining a malaria-free status, is to avoid the resurgence and re-establishment of 
malaria [117]. In order to achieve and maintain malaria elimination in Zanzibar, it will 
be necessary to uphold a high level of: 
 
Surveillance – To quickly identify a high proportion of new malaria infections. This 
can be done by upgrading the current Malaria Early Epidemic Detection System 
(MEEDS) passive detection and expanding it to include all public and private health 
facilities. Once a positive case is reported, surveillance officers should follow up the 
case and screen family members and surrounding households through re-active case 
detection. Pro-active case detection may also be considered for the screening of those 
who are considered to be at high risk of malaria [117].  
 
Case management – Once a malaria infected person is identified, efforts should be 
made to clear parasitemia as soon as possible. In addition to the personal benefit of 
promptly curing a person from malaria, the public health effect of reducing the duration 
of infectivity to reduce possibility of onward infection is especially vital when 
approaching malaria elimination [46].    
 
Vector control interventions – To further avoid onward transmission by an infected 
individual, vector control efforts should be in place to reduce vectorial capacity. 
Reduction of the mosquitoes' daily survival rate is possible with IRS, and to a lesser 
extent by ITNs. A reduction of feeding frequency by disrupting human-vector contact 
is also achieved with ITNs [1] .     
 
Community involvement – Just as community involvement was seen as an important 
component in malaria control [190], full collaboration from the community is believed 
to be needed in order to achieve and maintain elimination. This includes participation in 
all stages of  the elimination efforts, from planning to implementation [117]. IEC and 
BCC activities should encourage community members to go for malaria testing with 
each febrile illness, and to accept and adhere to treatment regimens and preventive 
measures.  
 
Commitment by the government and international donors – Leadership and strong 
political will is needed when embarking on the long and costly elimination goal. It is 
expected to become increasingly challenging to continue prioritizing an illness that is 
becoming rare when other illnesses are inflicting high burdens of morbidity and 
mortality. Additionally, it will become harder to maintain the external development 
partner's financial support. Targeting elimination is more costly than maintaining 
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controlled low-endemic malaria, mainly due to higher expenditures on surveillance and 
diagnosis, as well as management costs [117, 191]. 
 
The decision to target elimination rather than continuing with sustained control has 
programmatic, operational and financial consequences. In a highly vulnerable and 
receptive area like Zanzibar, these include maintaining extremely high levels of malaria 
control, emphasis on surveillance and case detection, ensuring continued commitment 
and leadership and high community participation, as well as measures to reduce 
importation risk and capacity building [117].  
 
Methodological considerations  
Study design  
A great strength, but also a weakness, of the studies presented in this thesis is the fact 
that they assessed implementation of malaria control interventions carried out by a 
national control program. The strength was that following the Zanzibar experience was 
an opportunity to assess implementations under routine conditions. That, and the fact 
that this work was done in strong collaboration with the ZMCP, allowed us to identify 
and consequently address operational barriers in real-time. However, this was also a 
weakness since it was challenging to identify all the different details that may have 
affected the intervention outcomes. Since the interventions were not implemented 
simultaneously or in the same manner in all districts, the differences observed between 
districts were sometimes difficult to interpret (Studies II & III).  
 
The three quantitative studies that were conducted were cross-sectional surveys. 
Therefore, although associations can be made through bivariate and multivariate 
analysis, the temporal relationships between the dependent and independent variables 
cannot be established [192]. For example, when finding an association between a 
perception and LLIN use, it should not be assumed that a certain perception is a 
determinant of LLINs use, when another plausible explanation could be that using 
LLINs has led to that perception (as was done in Study II). 
 
External validity 
External validity and generalizability are the extent to which a study's results can be 
relevant or applicable to other people or settings [192]. In general, while lessons 
learned from Zanzibar can be applicable to other SSA settings, Zanzibar is unique in 
several ways, and this should be considered before generalizing findings from Zanzibar 
to other SSA countries. First, Zanzibar is an archipelago, and thus its islands are 
separated and isolated from the African continent, which makes malaria elimination 
more feasible.  Additionally, Zanzibar is small in area and population size, and is thus 
easier to manage and access.  
 
External validity within the Zanzibar setting can also be affected by ways in which 
participants were selected in the different studies, and whether they are representative 
of the total population [192]. In Study I, adherence to ACTs was only assessed in 
caretakers who obtained the treatment at public health facilities. Assessing adherence in 
those who received treatment from the public sector might not be representative of 
those who received treatment from the private sector. However, ACTs in the private 
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sector were scarce at the time, as they were expensive and unaffordable to the majority 
of the population.  
 
In Studies II & III, the sampling was done from a list of households provided by the 
Shehas. As a result, only households registered by the Shehas were included in the 
surveys. Since LLIN distributions and IRS spraying are also done through registration 
with Shehas, there is a possibility that community members who are not registered, and 
therefore also lack access to control interventions, were not represented. Additionally, 
Studies II & III were conducted as part of yearly cross-sectional malaria surveys that 
are routinely done in Micheweni and North A districts. Assessing effective coverage of 
vector control interventions in 2006 and again in 2009 was an opportunity to compare 
and evaluate changes over time. However, the repeated yearly interviews may have 
cause conditioning-effects, whereby behavior and reporting patterns are affected by the 
repeated interactions with the interviewers, as well as "research fatigue" or exhaustion 
[193]. To mitigate these effects, each year a random sampling within the pre-selected 
Shehias is done, so that the same households were not necessarily approached every 
year.  
 
In Study IV, caretakers who gave extensive responses in a previous survey were 
prioritized. Therefore, more empowered and outspoken individuals participated in the 
study. This may have led to an overestimation of the high self-efficacy and decision 
making power of the female interviewees, and thus affect the transferability of the 
findings.  
 
Internal validity and reliability  
Internal validity refers to how well a study succeeded in measuring what it was 
intended to measure and how confident one can be in the results interpretation and 
conclusions, while reliability is the consistency or repeatability of the findings [194].  
 
The way in which the information was collected may affect the internal validity of the 
studies. In Study II, bed-net usage was asked in a general manner rather than asking 
specifically about usage in the previous night, which is in line with the core RBM 
indicator. This way of asking about bed-net use may have resulted in an overestimation 
of usage.  However, the interviewers viewed the bed-nets, and less than 5% (31/612) of 
the nets that were reported to have been used by under-five children were not seen 
hanging above a sleeping area at the time of the interview. Nevertheless, the fact that 
the nets were hanging does not necessarily mean they were being properly used to 
cover the individuals sleeping under them. Asking about bed-net usage in this way also 
makes it problematic to compare the study findings with findings of other studies, 
including Study III.    
 
In Study III, some questions that are qualitative in nature were asked as closed-ended 
questions with dichotomous "yes"/"no" answers. This may have led, on some 
occasions, to answers that were not well thought out, and thus may have affected the 
reliability of the study. Perhaps a better way of asking these questions would have been 
using a Likert-like scale. However, in some instances, the closed-ended question would 
be followed by an open ended question in which the respondent was asked to elaborate 
on the dichotomous answer given.  
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Recall limitations may compromise the validity of the responses [193].  Limitations in 
recall may have affected the way in which caretakers reported on drug administration to 
their children in Study I. In order to minimize this limitation, interviews were 
conducted on the fourth day of receiving the medicine, only one day after the three day 
dose-regimen was supposed to have been completed.  
 
In Studies II & III, detailed information from the distribution process may have been 
affected by recall limitations, as the distribution had taken place up to 9 months prior to 
the survey.   
 
Social desirability bias is when respondents take social norms into account when 
responding to verbal interviews [193, 195]. This bias may have been enhanced due to 
the fact that interviewers of quantitative surveys were all health professionals, and also 
due to the fact that in the consent form it was mentioned that the ZMCP was involved 
conducting the survey. Thus, caretakers may have felt compelled to over-report 
adherence to malaria control measures such as correct intake of ACTs (Study I) or use 
of bed-nets (Studies II & III). In Study I, desirability bias was mitigated by confirming 
the self-reported adherence with pill count. In Study II, an assessment of self-report 
error was done by verifying that the reported nets were in fact hanging above a sleeping 
space. 
 
In Study IV, the interviews were conducted by foreign researchers using interpreters. 
This may have affected the trustworthiness of this study by increasing social 
desirability aspects, as well as the possible impact that the interpreter may have on the 
findings [196]. This was mitigated by training the interpreters on the interview guide 
and considering only the dialogue between the interpreter and informant when 
analyzing the data.         
 
Triangulation refers to combining different data collection methods or disciplines to 
address a research question [197]. The thesis includes both qualitative (Studies I, II & 
III) and quantitative methods (Study IV), and Study IV involved researchers from the 
fields of public health and psychology. In this thesis, findings from the different studies 
are combined to present a comprehensive picture of patterns in malaria control uptake 
and its implications on malaria elimination.  
 
Ethical considerations  
Although ethical clearance was granted, in Study I there was an ethical dilemma related 
to the follow-up of caretakers in their homes without their initial approval. However, 
since malaria is not a stigmatized illness, it is believed that obtaining informed consent 
upon arrival to the household was sufficient. 
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CONCLUSIONS AND IMPLICATIONS  
Findings of this thesis indicate that caretaker uptake of malaria control interventions for 
children remains high in Zanzibar in the face of declining malaria burden. ACTs, freely 
provided at public health facilities, were relatively well adhered to, and the high 
effective coverage of IRS with the satisfactory effective coverage of LLINs, together 
provided an almost perfect effective coverage by vector control interventions. This high 
effective coverage elevates the prospects of achieving elimination in Zanzibar.  
 
Adherence to ACTs was found to be relatively good, taking into consideration the fact 
that the drug was not co-formulated or ideally packaged. Sub-optimal adherence to 
ACTs compromises curing the patient, has implications on resistance and prolongs the 
duration of infection, thus increasing opportunities for onward transmission. The 
findings suggest that providing dose-specific blister packs (which were adopted in 
2010), as well as improvements in health workers' prescribing and dispensing practices, 
would improve adherence.  
 
ACTs are provided free of charge through the public sector, and efforts are being made 
to expand their access in the private sector by providing affordable ACTs through 
AMFm. Also, in addition to elevating caretaker adherence, improving health workers' 
prescribing and dispensing practices will also improve access to correct dose regimens.  
 
Vector control interventions are currently highly dependent on delivery by the 
government through the support from external funders. IRS application requires highly 
skilled and professional staff, and therefore it is necessary that they are implemented 
under the management and control of health services. LLINs and ITNs, one the other 
hand, may be delivered through complementary delivery strategies to elevate their 
access. However, the possibility of community members to obtain LLINs and ITNs 
independently is impeded by increasingly high costs. Access to LLINs, for example, 
may be enhanced through the private sector by providing affordable and highly 
subsidised nets, similar to the way ACTs are provided through the AMFm.  
 
Community acceptance of IRS and adherence to bed-nets have a substantial effect on 
the overall effective coverage of these interventions. Findings in this thesis suggest that 
IRS is well accepted while sub-optimal adherence levels to LLINs compromise their 
effectiveness. Therefore, there should be emphasis on the importance of LLINs in order 
to increase the adherence levels. 
 
Community members' perceptions of the malaria control interventions were generally 
positive, while risk perceptions of malaria were low. Although there was no evidence 
of these perceptions' actual influence on adherence, it is important to maintain positive 
attitudes towards malaria control interventions. This can be done through different 
IEC/BCC activities, and it is important that these activities engage the community from 
the early stages of planning and implementation. Thus, ways of engaging the 
community in the elimination process should be pursued.  
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Recommendations 
 
1. Improving health workers' prescribing and dispensing practices would enhance 
access to correct dose regimens according to the national guidelines, in addition 
to having a positive effect on caretaker adherence. 
 
2. Since high effective coverage by vector control is mainly upheld by high IRS 
coverage, scaling back IRS should be reconsidered until a higher effective 
coverage of LLINs is obtained.  
 
3. Although mass distributions of LLINs can achieve satisfactory and equitable 
effective coverage, the establishment of a continuous delivery strategy should 
be considered for maintaining high effective coverage.  
 
4. Affordable LLINs should be made available in parallel to the free mass 
distributions in order to elevate their access and complement the governmental 
delivery strategies.   
 
5. Raising the adherence to LLINs is necessary in order to achieve high effective 
coverage. IEC/BCC activities should therefore focus on elevating positive 
attitudes towards LLINs to increase adherence.   
 
6. Emphasis should be placed on efforts which increase community participation 
and ownership in order to ensure community engagement and acceptance of 
malaria elimination efforts.  
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